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Background: Given the anticipated increase in the use of cannabis due to legalization, there is a 
need for more cannabis education for the general population. Since youth are particularly 
vulnerable to the effects of cannabis, new education programs are being implemented in some 
school curriculums. Evaluative tools are needed to assess cannabis knowledge, understanding 
and intention for use. Such tools could help determine whether these new cannabis awareness 
and education programs are effective.  
Methods: During the first phase of this study (questionnaire development) a Cannabis 
Knowledge Assessment Tool (C-KAT) and Behavioural Intention (BI) scale were created 
through a multistage iterative process. The C-KAT development involved the use of the Delphi 
method, whereby a purposive sample of healthcare professionals, policymakers, academics, 
patients who used medical cannabis and teenage students served as the content and development 
experts. Four rounds of the questionnaire were distributed prior to reaching consensus on the C-
KAT content. The BI scale was developed through consultation with six additional educators 
(with expertise in assessment, questionnaire development and biostatistics) and three students. 
During phase two of the study (testing), the C-KAT and BI scale were administered as a pre- and 
post-test in four schools (Grades 7 and 9) in Saskatoon, SK. The data were analysed to determine 
whether knowledge scores and behavioural intentions of the students changed after participating 
in a cannabis education program (REACH; Real Education About Cannabis and Health). 
Results: The questionnaire was administered to 132 students, of which 73 (55.3%) were in grade 
7 and 59 (44.7%) were in grade 9. In total there were 84 (63.6%) females, 46 males (34.8%) and 
2 (1.5%) students who identified as “other”.  The C-KAT scores increased in all students overall, 
and within each grade, gender, and school (p <0.05) following the REACH program, but the 
iii 
overall scores for the BI scale had no statistically significant change between pre- and post-test. 
Follow up could not be obtained with 281 students due to disruption of the study by the COVID-
19 pandemic (March 2020). 
Conclusion: According to the C-KAT scores, grade 7 and grade 9 students appeared to increase 
their knowledge about cannabis after participating in the REACH program. However, BI scores 
with respect to intentions for cannabis use were not impacted. More study is warranted to 
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Cannabis is a psychoactive drug with possible dose-dependent medicinal properties, 
which were first identified in traditional Eastern medicine around 5000 years ago. 1Although it 
has been around for many years, its consumption has been illegal in many parts of the world. In 
Canada, cannabis used for medicinal purposes was legalized in 20011 while adult recreational 
use of cannabis became legal on October 17, 2018.2  This legalization presents increased 
opportunities for research on cannabinoid compounds and their use in various medical 
conditions. Cannabis is being explored for the treatment of many different medical conditions 
ranging from seizure disorders and multiple sclerosis3 to neuropathic pain.4,5 Given the 
anticipated increase in the use of cannabis due to legalization6 it will be important for people to 
be educated so that it may be used in a safe and informed manner.  
In 2016, the UN World Drug Report concluded that cannabis was the most widely used 
illicit drug within the general population and younger populations worldwide, and cannabis 
consumption continues to increase.6 Youth are particularly vulnerable to the adverse effects of 
cannabis if consumption begins at a young age.7  Based on the Canadian Addiction Survey and 
the Canadian Alcohol and Drug Use Monitoring Survey, the age of first consumption of 
cannabis in youth fluctuated between an average low of 15.5 years and an average high of 16.1 
years from 2004 to 2012,7 and the use of cannabis in Canadian youth is among the highest in the 
world.8 Data indicates that the frequency of substance use increases substantially from early 
adolescence, peaks in early young adulthood and declines throughout adulthood.9 In 2017, 1 in 5 
individuals from the age of 15 to 19 and 1 in 3 individuals from the age of 20-24 reported using 
cannabis. 8 In 2016 it was reported that 17.6% of postsecondary students had consumed cannabis 
within the last 30 days.8  
2 
The recreational use of cannabis is not without risk. A higher frequency of cannabis use 
in adolescents is associated with increased reports of depression and anxiety later in life.10 
Studies have shown that those who consume cannabis more frequently over long periods of time 
experience physical, mental health, and cognitive challenges11,12 while developing tolerance and 
dependence to the drug.13 These data highlight the urgent need for increased knowledge and 
education concerning the use of cannabis. 
The Canadian government has faced considerable challenges implementing the 
legislation of legalized recreational cannabis use. Some of the reasons include various levels 
of public knowledge, concern for substance abuse in vulnerable populations, and the effects on 
those with low socioeconomic status.14,15 While educational interventions exist to address public 
concerns and prevent youth from cannabis misuse or promote the awareness of both beneficial 
and adverse effects of the drug,16–18 these appear to be few and far between. Furthermore, these 
may be viewed as outdated, as they were created in an era where the consumption of cannabis 
was illegal. Of the limited educational programs that exist, there appears to be no evaluations of 
the effectiveness of these interventions in the literature. Evaluative tools are needed to assess 
cannabis knowledge, understanding and intention for use. Such tools could help determine 
whether these new cannabis awareness and education programs are effective and to measure 
baseline knowledge and intent in various populations.  
In 2019, the Real Education About Cannabis and Health (REACH) program was 
developed and implemented in 4 schools in Saskatoon, SK. The intent of this program was to 
educate school aged children about cannabis so that they can make informed decisions about its 
use. The purpose of this project was to develop a tool which could evaluate the effectiveness of 
cannabis educational programs such as this one.  
3 
2. OBJECTIVES 
Objective 1: Develop a cannabis knowledge assessment tool (C-KAT) through the iterative 
multistage collection of expert opinions from health care professionals, students, policy makers, 
patients, and academics involved in this field of research through the use of the Delphi Method. 
Objective 2: Develop a behavioural intention (BI) scale through consultation with experts in 
assessments, questionnaire development and biostatistics.  
Objective 3: Determine if the developed questionnaire (C-KAT and BI scale) results in 





The understanding of cannabis in society and in science continues to evolve. Therefore, 
the perceptions of cannabis risks are continuously changing while the scientific details of the 
effects of cannabis on the body emerge. As Canada takes a public health approach to the 
legalization of recreational cannabis, there has been an increase in public awareness campaigns 
and education programs, especially aimed at youth. One such education program is the Real 
Education About Cannabis and Health (REACH) program implemented in Saskatoon, 
Saskatchewan. Initiatives such as REACH must be evaluated to determine the scale of their 
impact on youth’s knowledge of cannabis and healthy approaches to cannabis use. This task can 
be managed with assessments of knowledge and behavioural intention developed through formal 
consensus formats such as the Delphi Method.  
The following sections will delve into the background of cannabis and approaches to the 
assessment of knowledge, which will be necessary for the development of the Cannabis 
Knowledge Assessment Tool and Behavioural Intention Scale.  
3.1. Cannabis Throughout the Ages 
Cannabis is a plant that has been used for recreational purposes due to its psychoactive 
effects and as a medicinal drug. Policies and regulations regarding the consumption of cannabis 
have continuously changed throughout the years and around the world.  
The earliest documentation of cannabis use was in the early 3rd Millenia BCE where the 
plants known as hemp served various purposes.19 Practically the fibers derived from the plant 
were used in instrumentation such as rope and clothing. It was also widely consumed in medicines 
and food and its psychogenic properties were employed in religious and spiritual practices.20 
Cannabis domestication seems to have been first noted 12000 years ago during the early Neolithic 
period in East Asia where it was cultivated and processed in various forms.21 Cannabis cultivation 
was also documented in the Sumerian and Assyrian culture where the plant was often employed 
as a remedy for bronchitis, bladder infections, rheumatism and insomnia.22 The wide use of 
cannabis and its by-products as medicine occurred in central Asia approximately 5000 years 
ago.1,23,24 The first use of cannabis as medicine was by Chinese Emperors who passed their 
teachings down by word of mouth and later in Chinese books of herbal remedies.25 For example, 
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various Chinese pharmacopeias documented the use of cannabis in relieving blood clots, 
tapeworm, and constipation.25 
Although the specific origins of the use of cannabis remain a mystery, its introduction 
globally stem from its transition from Persia into Arab culture in 1230 CE and then again to Egypt 
in 12 CE.26 During this period of time cannabis was consumed as an edible in a form known as 
hashish.26 Use of the plant expanded into Africa and was introduced into Europe by Napoleonic 
Soldiers enroute from Egypt and then transported to the western hemisphere by colonizers via 
Chile around 1545.27 
For years, cannabis has served as a remedy for various ailments including migraines, gout, 
dandruff, amenorrhea and depression.28 However, the use of cannabis has been debated and 
subsequently legislated throughout time. The earliest known legislative action against cannabis is 
during the medieval period in traditionally Islamic countries, in which its use was punishable by 
capital punishment.29 By the 1800s cannabis was banned and criminalized in Egypt and Morocco 
and later throughout the world, such as the United States, The United Kingdom, New Zealand, 
South Africa, Canada and Jamaica.30  Legislations enforced the prohibition of the use, import and 
export of the plant.30 One reason for its prohibition was the fear of recreational cannabis leading 
to increased rates of crime and violence, which motivated the banning of the substance around the 
1930s and 1940s.1 However, in the last few decades interest in the use of medicinal cannabis has 
once again increased and medicine containing cannabis components or synthetic cannabis are 
available by prescription in some countries.31 
Aside from medicinal and agricultural uses, cannabis may also be used in a recreational 
capacity due to its psychoactive effects. According to the United Nations Office on Drug and 
Crime, cannabis is currently the most popular recreational drug in the world, and cannabis 
consumption has continued to increase in the last few decades.15 Such increases have been shown 
to be due to a decreased perception of risk associated with cannabis and due to the legalization of 
cannabis in some parts of the world.32,33 Individuals aged 15 to 19 and 20 to 24 are the largest 
demographic for cannabis consumption in most countries, including Canada.15 
The global increased rates of cannabis use are also in part due to the rapid advances in 
cannabis cultivation technology in the last two decades, which have increased cannabis 
production in almost every country.15 As a result of these new technologies, selective breeding of 
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the cannabis plants for a more psychoactive experience along with the availability of new modes 
for cannabis consumption, such as vapes, oral sprays and topical methods, have increased.34 
3.2. Cannabis and the Endocannabinoid System 
Cannabis comes from the genus Cannabis in the Cannabaceae family of plants. This 
family of plants is native to countries with temperate and tropical climates and has several 
species, including two of the more commonly known species, Cannabis sativa and Cannabis 
indica.24 While cannabis is composed of over 400 known chemicals, the compounds of interest in 
cannabis research are often the phytocannabinoids. 24 Cannabinoids that are produced in the 
human body are called endocannabinoids and are ligands for the endocannabinoid system (ECS), 
and function as signaling molecules on the cannabinoid receptors in the ECS. The two major 
endocannabinoids are anandamide (AEA) and 2-Arachidonoylglycerol (2-AG).35 Although other 
peptides and arachidonic acid derivatives that interact with the ECS continue to be discovered, 
AEA and 2-AG remain the most studied.35 When phytocannabinoids are ingested they have an 
effect on the ECS. 36 Currently, synthetic cannabinoids, such as nabilone which mimics THC, are 
also being developed and researched for their therapeutic uses. 1 
It was not until the 1980s that the location of action of the phytocannabinoids, the 
cannabinoid receptors (CB1 and CB2), along with endocannabinoids such as AEA and 2-AG, 
were isolated.37 CB1 and CB2 differ in their primary protein sequence, signalling mechanisms, 
tissue distribution along with sensitivity and selectivity for activating and inhibiting compounds.38 
However, both these receptors are part of the G-protein coupled receptor (GPCR) family.37 
Therefore, activation of the cannabinoid receptors inhibits some calcium channels along with 
adenylyl cyclase while activating protein kinases and some potassium channels.38,39 As part of the 
ECS, these receptors facilitate the inhibition of neurotransmitter release through their variety of 
effects on synaptic function, gene transcription, and cell motility.38 The endocannabinoids, AEA 
and 2-AG, function through retrograde signalling. Endocannabinoid synthesis enzymes are 
present in the postsynaptic terminal of the neuron.40 Therefore, following their synthesis in the 
post synaptic terminal, AEA and 2-AG are released and travel through the synaptic cleft to the 
presynaptic terminal40 which is the opposite of the common pathway for signal transmission. At 
the presynaptic terminal, the endocannabinoids act on CB1,37,39,40 resulting in decreased 
neurotransmitter release from the presynaptic terminal and therefore synaptic depression. 40 
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CB1 is present in low levels in peripheral organs, however it is the most abundant GPCR 
in the brain.37 In the rodent brain, CB1 concentrations are highest in the basal ganglia, substantial 
nigra, globus pallidus, cerebellum, and hippocampus which are sensory and motor regions.37 As a 
result, CB1 is involved in cognition, memory reward, pain perception, and motor coordination.36 
CB1 is present from embryonic stages therefore indicating its importance in neural development. 
However, the distribution and abundance of CB1 changes throughout development. In the 
neonatal brain, CB1 is mostly present in white matter but this decreases later in life and the 
overall concentration of receptors increases from adolescence to adulthood.41 While DNA variants 
can result in CB1 gene polymorphisms, the importance of these variations of the receptor are not 
yet established and may involve predisposition to addiction or cannabis dependence35,42 and 
neuropsychiatric conditions.42 The structural changes of CB1 and CB1 variations during activator 
binding continue to be studied to determine the signalling process along with pharmacological 
and physiological properties of the receptor.35 
CB2 is more commonly distributed in the immune and gastrointestinal system20 and is also 
present throughout the central nervous system (CNS), such as in microglial cells, but is not as 
abundant as CB1 in this region.37 The expression of CB2 has been shown to increase under some 
pathological conditions, such as nerve injury, and is therefore considered a protective system.37,40 
Following tissue injury and/or inflammation, CB2 expression can increase up to 100-fold.40 As a 
result, CB2 and synthetic CB2-specific activators are widely studied for clinical use.37 Although a 
link has been made between CB2 and increased schizophrenia risk,43,44 uncertainty remains 
regarding which type of CB2 is involved in this link.40 While the two major cannabinoid receptors 
in the ECS are CB1 and CB2, transient receptor potential (TRP) channels and peroxisome 
proliferator activated receptors (PPARs) can also be activated by the phyto- and 
endocannabinoids.1,40  
The main phytocannabinoids known thus far include delta-9-tetrahydrocannabinol (THC), 
cannabidiol (CBD) and cannabinol (CBN). The primary psychoactive component of cannabis, 
THC, was first isolated from the cannabis plant in 196445 and then later synthesized for use in 
research in 1967.46 THC binds to ECS receptors in the central and peripheral nervous system to 
modulate neurotransmitter release similar to the endocannabinoid ligand, AEA. Therefore, THC is 
termed a mimetic phytocannabinoid for AEA.47 Acute pharmacological effects of THC due to 
binding and activation of CB11 include euphoria, relaxation, perceptual alterations, increased 
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appetite, time distortion, anxiety and panic, impaired attention and memory, an increased risk of 
psychotic symptoms, disorientation, and psychomotor effects.48 Additionally, it has been noted 
THC under prolonged storage will breakdown to CBN, therefore the ratio of CBN to THC can be 
used to determine the age of cannabis samples.49 
CBD was one of the first cannabinoids to be isolated in the 1930s, however as CBD does 
not have the psychoactive effects of THC there was limited initial research interest in CBD.37 
CBD functions as the mimetic phytocannabinoid for 2-AG and has been observed to enhance 
learning while exerting antipsychotic, anti-inflammatory and anti-anxiety effects.50 However, 
CBD reduces the reuptake of AEA, thus antagonizing the side effects of THC such as anxiety, 
sedation and tachycardia.1,50 Both THC and CBD have been noted to have analgesic effects;1 
however, it has been shown that THC’s analgesic activity is a result of its activation of CB1 while 
CBD’s analgesic effects results from its binding of pain-mediating proteins such as TRP channels 
and anti-inflammatory mechanisms at injury sites.1 While there are over 100 cannabinoids in 
cannabis, including CBN, due to THC’s psychoactive properties and CBD’s anti-inflammatory 
properties, these two cannabinoids are currently the focus of most research.  
Since THC and CBD exert different actions, the ratio of each of these cannabinoids in 
cannabis products can result in different effects on the user. For example, Karniol et al.9 
performed a double-blind study in which 40 healthy male volunteers were given different 
concentrations and combinations of the cannabinoids. The experimental groups included 30 mg of 
THC, 15, 30 or 60 mg of CBD or mixtures of 30mg of THC with either 15, 30 or 60 mg of CBD. 
The group ingesting 30 mg of only THC demonstrated increased pulse rates, decreased motor 
function and intense psychological reactions. The group taking different concentrations of CBD 
without THC experienced no effects in the abovementioned parameters; however, CBD was 
successful in blocking these negative effects of THC when combined and helped reduce the 
anxiety associated with THC.9 Furthermore, different cannabis plants contain varying ratios of 
THC and CBD due to the strain type of the plant, along with environmental and harvesting 
conditions such as cultivation, storage and age at time of harvest. For example, the Indica strains 
of cannabis have a greater ratio of CBD content than THC, while Sativa strains have a higher 
THC content than CBD.36,51 Also, hemp that is used for industrial products, such as textiles, has 
been regulated to contain less than 0.3% THC while cannabis in the 1960s contained around 2% 
9 
to 3% THC.37 However, newly developed and often unregulated strains of cannabis may contain 
up to 25% THC.37 
3.3. Medicinal Use of Cannabis  
Understanding the components of cannabis and their functions in the endocannabinoid 
system allows researchers to explore the use of cannabinoids in medicine and create synthetic 
drugs that mimic cannabinoids for beneficial medicinal purposes. The implementation of laws and 
sanctions were developed by each country that legalized cannabis for medicinal use. The 
legalization of medicinal cannabis in Canada occurred in 20011 and will be explored in this 
section along with an overview of current medicinal cannabis uses.  
3.3.1. Legislative Actions Related to Medicinal Use of Cannabis  
Prior to legalization, public opinion in Canada had been in favour of cannabis 
decriminalization. Over half (51%) of those polled in 1997 supported the sentiment while 71% of 
Canadians were in favour of the use of cannabis for medicinal purposes.52 The legalization of 
medicinal cannabis, which occurred in 2001, resulted in the creation of the Marijuana Medical 
Access Regulations (MMAR), which entitled specific individuals to access the dried cannabis in a 
medicinal capacity.1 The MMAR allowed patients to apply for access to Health Canada’s supply 
of dried cannabis through authorization from their health care practitioner, and/or apply for 
personal-use production licensing.1 In 2014, MMAR was transitioned into the Marijuana for 
Medical Purposes Regulations (MMPR) as Canadian officials created conditions for cannabis to 
be produced and distributed in a commercial capacity by licensed producers.1 Following the 
implementation of MMPR, patients with appropriate authorization from their physician could 
access dried cannabis for medicinal purposes by submitting their documentation to a Health 
Canada-approved licensed producer of cannabis.1 Physician authorization documents are 
equivalent to a prescription and specify the specific strain and THC content of the product, when 
necessary, along with patient information and daily intake specifications.1 As cannabis was 
treated like a narcotic under the MMPR, it was recommended that physicians use patient-
physician agreements, informed consent and frequent follow-ups when recommending medicinal 
cannabis.1 
In 2015, the restriction of medical cannabis to dried products was lifted and those with 
medical need were provided access to other cannabis products such as cannabis oil, fresh plant 
buds and leaves along with dried cannabis. 53 However, medical users found that they did not 
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have reasonable access to the drug they required due to commercial restrictions and in 2016 the 
Access to Cannabis for Medical Purposes Regulations (ACMPR) replaced the MMPR. 53 The 
ACMPR provided a framework for safe and sanitary commercial production by licensed 
producers. It also allowed licensed producers to sell cannabis plant seeds which allows individuals 
to produce their own cannabis plants for medicinal use. 53 
Since implementation of the Cannabis Act for recreational cannabis use in 2018, the 
regulations surrounding medicinal cannabis have also changed and replaced the ACMPR.54 Along 
with buying from licensed sellers or registering to grow their own cannabis plant for medicinal 
purposes, patients are also able to purchase the drug at authorized retail outlets and online sales 
platforms, permitting of legal age limits and provincial policies.54 These changes have greatly 
increased access for medical users. 
3.3.2.  Cannabis as Medical Treatment 
Initially the MMPR only permitted dried cannabis goods to be accessed. However, 
regulations continued to evolve to provide sufficient avenues for accessing cannabis products in 
different available forms.1 The ideal route of administration of medicinal cannabis depends on the 
ailment that is being targeted and the preferred method of the patient. Cannabis can be consumed 
through variety of routes, including smoking, vaporization, oral or sublingual ingestion. Often, 
medicinal cannabis smoke is not preferred due to the concerns of carcinogenic chemicals, but 
vaporization, oral ingestion or sublingual tinctures are also available.1 For those with respiratory 
illness, oral ingestion methods of cannabis such as oils and edibles are preferred.  There is, 
however, an increased latency of effect with this method, which may lead to some patients 
readminister a repeat dose too early.1 Currently, inhalation methods such as smoking and 
vaporization are the most frequently used method of medicinal cannabis consumption.1 Less 
frequently used methods include transdermal ointments, ophthalmic drops and rectal 
suppositories.1 Further research is required to determine the use and therapeutic benefit of these 
routes of administration, as this is currently unknown.  
Although cannabis has been used in traditional medicine and religious ceremonies for 
many centuries in countries such as China and India, its use in western medicine practices only 
started to be explored in the 19th century.1,50 By the late 19th century, medicinal cannabis was 
widely accepted for a variety of conditions, especially pain.1 With evidence for the clinical uses of 
cannabis continuing to emerge,1 some cannabis-based medications have been approved for 
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clinical use. In 2005, Canada approved Sativex (nabiximols) for multiple sclerosis.1,23 Sativex is a 
sublingual spray that contains THC and CBD.23 Since its approval, Sativex has become available 
in more than 27 countries23 and its use is also being investigated for fibromyalgia.1 In 2018, the 
United States Food and Drug Administration (FDA) approved the use of Epidiolex, which is an 
oral solution of pure CBD for the treatment of epileptic seizures.55 Epidiolex has been researched 
in controlled trials in youth with epilepsy and has been found to be tolerable for patients while 
significantly improving motor seizures.56 Other FDA approved medications containing 
cannabinoids include dronabinol and nabilone, which are often prescribed as antiemetic 
medication for cancer chemotherapy,57,58and appetite stimulation for patients, such as those with 
HIV,3 anorexia, or ALS.59,60 Nabilone has been found to increase quality of life and decrease pain 
severity in patients with therapy-resistant chronic pain when administered in conjunction with 
current therapies.61 Patients with fibromyalgia experienced improvements in pain management 
and quality of life following nabilone use.61 Furthermore, orally administered cannabis extract has 
been found to reduce the frequency of muscle spasms and thereby increasing motility in patients 
affected by multiple sclerosis.3,59A large study in 2015 showed that a majority of patients with 
fibromyalgia, arthritis and neuropathic pain reported substantial or complete relief from their pain 
with the use of cannabis.62 These patients also reported being able to decrease their intake of other 
medications, including opioids.62 
In 2004, around 4% of Canadians over the age of 14 indicated using cannabis once or 
more in the past year to self-treat a medical condition.1 While medicinal cannabis programs show 
that 0.68 to 1.5g of cannabis are used per day by medical users, patient self-reports in Canada 
show up to 10g being used per day and 40% use more than 14g per week.1 Therefore, the self-
reported amount of consumption may far exceed the typical amount recommended medically. 
Several individuals in Canada (including some youth), continue to self-medicate without an 
authorization.  
3.4. Legalization of Recreational Cannabis 
Although medical cannabis use has been legal in Canada for around two decades,1 the 
recreational use of cannabis continued to have an illicit status until the implementation of the 
Cannabis Act, on October 17th, 2018.2  Worldwide, Canada is the second country, (following 
Uruguay in 2015), and the first country in North America to legalize recreational cannabis 
consumption on a federal level.64 While peer-reviewed research was limited prior to the creation 
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of the Cannabis Act,64  the legalization of cannabis has since allowed for increased areas of 
cannabis research,54 including studies on the impact of recreational legalization on medical users, 
changes in societal perceptions of cannabis, use in youth and the short term or long term benefits 
and consequences of cannabis use. In this section a summary of the Cannabis Act is presented, 
along with the implications of recreational cannabis legalization on the perceptions of cannabis 
and the use of cannabis in youth and adolescence.  
3.4.1.  The Cannabis Act 
As indicated by the Government of Canada, the purpose of the Cannabis Act is to “protect 
public health and public safety” by specifically restricting access and initiation of cannabis in 
youth, providing opportunities for legal production of cannabis to decrease illicit production and 
other illicit activities surrounding cannabis thus reducing the burden on the criminal justice 
system, to regulate the quality of cannabis supply and increase public education of health risks 
related to cannabis use. 63 
The Cannabis Act ensures that the production, distribution, sale and possession of 
cannabis in Canada is regulated.65 Provinces and territories also play a role in regulation, and 
therefore, there is a lack of consistency in cannabis governance across Canada.66 Quebec has the 
oldest legal age of cannabis use at 21 years old while Alberta has the lowest with 18 years old.67 
All other provinces have set the legal age of cannabis use at 19 years old.67 All provinces have a 
public possession limit of 30 grams of dried cannabis or equivalent 63, 67 and recreational cannabis 
must be purchased through licensed cannabis retailers. It is a criminal offense for individuals 18 
or over to possess cannabis that they know is from an illegal source and penalties include a fine or 
imprisonment. 63 However, to protect the well-being of the public and those in distress, no person 
seeking medical or law enforcement help during a medical emergency for themselves or for 
someone else at the scene will be charged or convicted if illicit cannabis use is detected. 63 
The provinces and territories in Canada are also responsible for developing their own 
regulatory framework for the retail of recreational cannabis.68As a result, the legal cannabis stores 
in Canada are government-operated, privately-operated or a mixture of both (hybrid) and can be 
operated through physical and/or online stores. As of September 2019, private and hybrid retail 
models accounted for 65% of cannabis sales.68 From March 2019 to July 2019 there was an 88% 
increase in the number of cannabis retail stores in Canada, from 217 to 407,68 and in 2021, a total 
of 1183 legal cannabis stores were reported.69 The lowest number of stores per capita is in Quebec 
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and Ontario and the highest is in Alberta and Yukon.69 As the number of licensed retail options 
increase for cannabis purchase, the perceptions and prevalence of recreational cannabis is also 
expected to change.  
3.4.2.  Recreational Use 
The recreational use of cannabis is often motivated by the psychoactive effects of the 
substance and the enjoyment of the “high” that this can produce.70 A study found that medicinal 
cannabis users who sought cannabis with high THC content were more likely to report also using 
cannabis recreationally while those seeking high CBD content were less likely.71 These findings 
support other studies that report recreational users prefer cannabis with high THC content for the 
psychoactive effects72 while CBD is beneficial for medicinal uses and is not preferred by 
recreational users.73 A 2016 national survey performed in the United States showed that among 
those who use medicinal cannabis, 77.5% reported also using cannabis recreationally74 while 
another study in 2019 with a smaller sample size reported 55.5% of those using medicinal 
cannabis also used cannabis recreationally.71 There rates are higher than the rates of past-month 
cannabis use among American adults over 18 years old71 meaning there is greater recreational use 
in those already using cannabis medically. The route of administration for recreational cannabis 
can also depend on the desired experience of the “high” for users. For example, psychoactive 
effects of cannabis have varying onset depending on the route of administration. Smoking, vape, 
tinctures have a fast onset while edibles will have a delayed effect and topical cannabis has no 
psychoactive properties.71 
Although recreational cannabis is often used to enhance wellbeing, there is not much 
evidence to prove that cannabis use significantly improves quality of life.70 In fact, in some 
studies a dose-dependent effect is noted in which the consumption of cannabis beyond an amount 
can reduce quality of life.70 While studies have shown that cannabis has a comparatively low 
effect on quality of life when compared to other substances such as alcohol and tobacco, cannabis 
may have higher risk of harm in vulnerable populations such as youth and those predisposed to 
psychotic disorders.70 
Recreational use can be motivated by a variety of factors, including social, conformity, 
enhancement, coping, perception changes and mind-expansion effects or simply the intoxication 
experience.70 In youth, cannabis is often used for enjoyment and for social connection, but it is 
also used because of conformity and as a coping mechanism for negative emotions.75 Among 
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adolescents, perception of decreased risk is the greatest motivator for increased cannabis use since 
legalization.70 Research has shown that recreational legalization of cannabis can result in changes 
to perceived harm of the substance along with perceived social and legal.76 In a study by 
Amroussia et al.,76 perceived social risk is defined as how an individual believes others will react 
to them being a cannabis user while perceived legal risk is their belief about the severity of legal 
consequences of cannabis use. A focus-group study investigating the attitudes, perceptions, and 
behaviours of young adults toward recreational cannabis use in Nevada following legalization of 
recreational cannabis. The study found that participants were aware that there were rules and 
regulations surrounding recreational cannabis purchase and use but most participants had limited 
or vague knowledge of these regulations. While many of the participants did not believe that the 
legalization of recreational cannabis effected their use or nonuse, most agreed that legalization has 
improved perceived social risks of use. Also, recreational legalization was perceived as a harm 
reduction strategy as it may reduce use of worse substances, allow for better control of cannabis 
products and use and decreased the presence of drug dealers and negative consequences such as 
incarceration. In fact, it was found that following cannabis legalization in Canada, there was a 
55%-65% decrease in cannabis-related crimes among youth.77  Robinson et al.,78 studied 
Canadian youths’ opinions of legalization pre-legalization and post-legalization, and found that 
the students did not have negative views regarding cannabis legalization and that there was little 
effect on their perceptions following legalization.  
Research on the prevalence of cannabis use following recreational legalization in Canada 
and other countries has shown mixed results.66 In some cases, higher prevalence of cannabis use 
was reported following legalization. For instance, a study by Miech et al.,79 examined the 
cannabis-related behaviours of grade 8, 10 and 12 students in California compared to other states 
prior to and following the legalization of recreational cannabis in California. The study found that 
two years following the legalization of recreational cannabis, the students in grade 12 were 25% 
more likely to have used cannabis in the past 30 days, 20% less likely to strongly disapprove of 
regular cannabis use and 60% more likely to use cannabis in the next five years as compared to 
those in grade 12 in other states. However, these grade 12 students also showed high acceptance 
of cannabis prior to the decriminalization of cannabis, therefore these results could be due to 
cohort effect and the increased media coverage of cannabis in California instead of the 
decriminalization of cannabis. As a result, the study predicated that this high cannabis acceptance 
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would not be present in future cohorts as media coverage of cannabis had since decreased. 
Furthermore, no specific increases in cannabis acceptance were noted in the California grade 8 or 
10 students.79 Similar to the effects of media coverage on this study, other research mentions that 
the impact of cannabis legalization may be a result of how legalization is implemented instead of 
the act of legalization itself.80,81 
Other literature has shown no impact on adolescent cannabis use patterns. For instance, a 
cross-sectional cohort study examined the cannabis use of two cohorts of high-risk youth in 
Canada.66 Through the use of demographic and assessment questionnaires one cohort was 
evaluated prior to cannabis legalization and the other following legalization.66 The study found 
that the rate of cannabis use, multi-substance use, social circles of use and mental health did not 
change.66 The high-risk youth who participated in the study included patients enrolled in an 
outpatient addictions and substance use treatment program. The survey found that youth reported 
purchasing cannabis from legal sources following legalization and concealment of cannabis use 
from legal authorities declined for those over 19 years old.66 While research is still limited 
following the legalization of recreational cannabis in Canada, some studies have indicated an 
increased use of cannabis in the general public, while among young adults it has remained the 
same and has decreased among adolescents.82 Furthermore, the Ontario Student Drug Use Survey 
found no increase in prevalence of cannabis use from prior to legalization compared to after 
among students.83 Research in Colorado found no changes in cannabis use among adolescents 
following legalization in the state, however, most participants believed that cannabis has become 
easier to access.84 
As most studies on changes in cannabis perception and use have been performed 
immediately or closely following the recreational legalization, it is uncertain whether the results 
will be sustained. Therefore, the risk perception, prevalence and acceptance of cannabis use in 
Canadian youth requires subsequent research for greater understanding of the effects of 
legalization.  
3.5. Potential Adverse Effects of Cannabis 
Currently, most of the knowledge about the adverse effects of cannabis use are based on 
studies of recreational users. Cannabis use may result in long-term and short-term side effects in 
some individuals. 36 Furthermore, the side-effects that each individual may experience when 
consuming cannabis can vary36, as the rate of absorption and metabolism of the cannabinoids or 
16 
the tolerance can vary between cannabis users.58  For instance, chronic activation of CB1 by THC 
can cause downregulation of CB1 and result in increased tolerance to cannabis58 along with 
potentially increasing intake to counteract these effects. The concentration of THC can also 
influence the intensity and duration of the effects of cannabis use.58 
The clinical features of the “high” experienced with cannabis include users’ enhanced 
sensitivity to stimuli such as colours and music along with altered perception of time and 
increased appetite for sweet and fatty foods.58 However these clinical features of the pleasurable 
“high” are also associated with dry mouth, decreased short-term memory and impaired motor 
skills and can include panic attacks, paranoia or hallucinations when THC levels are high.58 As a 
result of the impaired motor skills that are associated with acute cannabis use, impaired driving 
abilities are a public health concern58, due to risk of trauma and injury from motor vehicle 
collisions.85 Also, the increased appetite caused by cannabis use has been associated with weight 
gain, which can increase the risk of obesity, a major risk factor in many chronic illnesses such as 
type 2 diabetes mellitus.58 
Several studies have also shown a dose-dependent link between cannabis use and 
psychosis.36,86,87 The risk of adverse effects, including decreased motivation, addiction, cognitive 
decline and psychoses, are greater in those with onset of use younger than 18, multi-substance use 
and family history of psychoses.56 A longitudinal study by Van Os et al.,88 showed that cannabis 
use increased the prognosis of psychosis in those with a family history or predisposition for 
psychotic disorder; however, cannabis use also increased the incidence of psychosis in those 
without a predisposition. In addition to increasing risk of psychotic disorders, cannabis use has 
also been associated with anxiety disorders and suicidal ideations.85 
Various physical, mental, behavioural and social health consequences have been 
delineated in correlation to long-term cannabinoid exposure, including symptoms caused by 
dependency to the drug.11,12 Chronic exposure to cannabis smoke has been correlated with the 
exacerbation of symptoms of chronic bronchitis symptoms, decreased lung function and 
malignant disease.48 Along with the increased risk of lung injury, other physical adverse effects of 
cannabis use include cannabinoid hyperemesis syndrome and arrhythmias85. As early and regular 
use along with high THC content are major risk variables for the adverse effects of cannabis, 
modifying cannabis risk behaviours early in adolescence is an appropriate public health approach 
to reduce long-term harms from cannabis.  
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3.6. Cannabis Knowledge in the General Public  
Since the implementation of the Cannabis Act, public education campaigns have increased 
surrounding cannabis use. However, studies have found that adults in the general public do not 
have adequate knowledge of cannabis. For instance, a survey conducted in 2019 assessing 
cannabis information sources and knowledge about the risks and effectiveness of cannabis found 
that 74%-81% of participants’ knowledge of cannabis was from their own personal experiences 
and only 18% received information from their primary care provider.89 Forty percent of the 
participants also believed that cannabis use did not increase risks, while 72% believed it was 
effective for treating cancer and 72% believed it was effective in treating depression.89 The same 
study found that the 18% of participants who received their cannabis information from their 
primary care provider had higher scores for knowledge of medical effectiveness. 89 Therefore, 
those who received information from a trusted and knowledgeable source had more accurate 
perceptions of cannabis risks.  
Another study conducted in Canada in 2011 observed 165 interviews with adult cannabis 
users and found that there was limited knowledge of the cannabis laws and policies.90 Once these 
participants were told about the cannabis laws, they described them as “excessive” and 
“ridiculous”. 90 This study by Brochu et al., 90demonstrates that while cannabis laws may be 
enforced, the adults who actually use cannabis may not be as knowledgeable about them as they 
should be.  
As cannabis use has been shown to be implicated in vehicle collisions and the 
development of psychoses, it is important for the general public to have sufficient and accurate 
knowledge about cannabis use and harm reduction when using cannabis.  Therefore, the 
knowledge of cannabis in the general public is an area that requires greater attention as the 
accessibility to cannabis increases.  
3.7. Potential Implications of the Use of Cannabis in Youth and Adolescence  
In addition to increasing the knowledge of adults regarding cannabis use, the health and 
development of youth and adolescents is an important component of public health strategies. 
Behaviours that begin or are reinforced during adolescence, including substance use, have short-
term and long-term impacts on the individual, their current and future families, and their 
communities.91 For example, an earlier start of substance use is associated with an increased long-
term prevalence of substance use and abuse, in addition to mental health problems, family and 
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workplace adjustment problems and physical problems.91 As a result, adolescence is a crucial 
period for preventive health policy measures.  
Adolescence is an essential period for neuro, psychological social development.91 The 
limbic system, which is in charge of pleasure seeking, reward processing, emotional response and 
sleep regulation continues to develop and is followed by changes in the frontal cortex which are 
responsible for decision making, organization, impulse control and planning.92–94 Magnetic 
resonance imagining (MRI) and positron emission tomography (PET) have made it possible to 
examine the effects of using cannabis at an early age on brain structures. Wilson et al., 95 found 
that individuals who started using cannabis prior to the age of 17 had abnormalities in brain 
structure, such as higher percent of white matter volume along with decreased whole brain 
volume and cortical gray matter. These individuals report deficits in attention, learning, recall, 
mental flexibility, and processing speed.95 
As a result of these important changes during this developmental period, logical moral 
thinking, abstract thinking, rational judgement, and understanding the perspectives of other’s 
increase.91 At the same time, self-identity and concerns over the opinions of their reference groups 
also develop. Reference groups include peers and friends, parents and one’s community.96 Stone 
et al.,96  studied the effects of perceived social norm trends and changes in cannabis use in the 
years following recreational cannabis legalization in Washington, and found that cannabis use by 
a close friend and perceived parental acceptance of cannabis use were associated with adolescent 
cannabis use. Therefore, the social and emotional changes during adolescence can increase the 
risk of behavioural problems such as substance use.91 
In addition to experiencing the negative acute and long term effects of cannabis use, youth 
have an increased risk of developing cannabis dependence, therefore leading to maladaptive social 
behaviours.97 Furthermore, frequent use of cannabis may have more damaging effects on the 
developing adolescent brain resulting in increased reports of psychotic disorders, depression and 
anxiety later in life,10 and 5 to 8 point drops in IQ scores.98 Cannabis use in adolescents in 
comparison to their adult counterparts has been proven to be more detrimental. For instance, 
Lynskey et al.,99 performed a review of studies which reveal that adolescents who consume 
cannabis have been shown to have lower grades, higher rates of dropout and higher rates of 
unemployment. Additionally, youth are more likely to participate in higher-risk activities, such as 
unprotected intercourse and driving while intoxicated, due to the cognitive and decision-making 
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impairment of cannabis. 100 As a result of cannabis use, which alters brain development when used 
at a young age, youth may be impacting future academic, professional and social aspects of their 
lives.100  
3.7.1. Cannabis Education in Youth and Adolescence 
The Government of Canada has committed around $46 million toward cannabis public 
education and awareness campaigns over the next five years.3 An additional $62.5 million was 
committed to support community-based and Indigenous organizations in the education of their 
communities.101 The federal government has also continued to engage in working groups with the 
provinces and territories along with Indigenous organizations and communities to discuss public 
education and awareness campaigns. Some early federal efforts include public opinion research 
regarding Canadians’ knowledge, attitudes, and behaviours related to cannabis along with market 
research to inform campaigns trying to reach youth, young adults and parents.101 While the 
Government of Canada continues to expand their public education campaigns with their 
partnerships,101 the most effective method of campaign delivery must be explored for the 
particular target audience of adolescents and youth.  
Often substance abuse is described as a family disease in which genetics and family 
environment are involved. Family environment factors that can affect substance use in youth 
include family structure and coping strategies, the parent-child relationship, the parental 
expectations, and the strength of the extended family network.102 Therefore, parents and the 
family unit play an important role in preventing and intervening with substance use. A study 
performed in 2015 showed that family-based programs that focused on the parent-child 
relationship were effective in preventing and reducing adolescent cannabis use;103 however, these 
results cannot be applied to at-risk populations, as factors such as family dysfunction and family 
history of substance use problems can create greater challenges for family-based education and 
therefore may not be as effective.102 Approaches that apply more intensive programing for such 
families based on risk factors and with the added goal of improving family functioning and 
reducing anti-social behaviours have been more effective for at-risk youth. 102 Also, studies have 
found that parents are unprepared and unsupported when it comes to acknowledging adolescent 
substance use within the household.103 Early childhood programs that involve substance use 
education, supporting parents in helping their children and home visits have been effective in 
preventing substance use along with the use of family therapy. 102, 103 
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When aiming to promote population health or preventing substance use, universal 
prevention measures are effective as they address an entire target population,102 such as youth and 
adolescents. Programs that can be considered universal prevention measures include awareness 
campaigns, school drug education programs and multi-component community initiatives.102 
Schools are an important site for universal prevention measures as they allow primary prevention 
efforts to be directed at a specific age range of the population.102 In their global consultation with 
adolescents, the World Health Organization found that 47% of participants preferred to received 
their health information from school and 46% reported being influenced by the health information 
they received from school.104 Therefore, school-based programs can effectively influence 
common risk and protective factors for a range of health behaviours,105 and in some instances over 
long-term settings.106 
A study on school-based interventions that compared knowledge-focused, social-
competence-focused, social norms-focused and combined interventions showed that the combined 
interventions reduced overall drug use.107, 108 Furthermore, for cannabis use, combined 
interventions also decreased use at follow-ups after 12 months.107, 108 Another report written by 
the Government of Canada detailed that education programs that incorporate life-skill approaches, 
such as decision-making, communication skills and assertiveness resulted in better outcomes for 
substance use prevention than programs focused on substance refusal.102 Previous studies 
surrounding alcohol and drug education have also shown that abstinence-focused measures lack 
student engagement.103 Therefore, school-based programs that integrate social competence and 
social influence education regarding cannabis use have protective effects in youth.107  
School-based cannabis prevention programs were found to be most effective in reducing 
cannabis use in those between 10-15 years old when they included antidrug information along 
with refusal skills, self-management skills and social skills training.107 In a study comparing 
school-based, family-based, and policy-based interventions, school-based programs were the most 
effective in reducing substance abuse.107 
3.7.2. The Real Education About Cannabis and Health (REACH) Program 
Real Education About Cannabis and Health (REACH) is a toolkit and curriculum resource 
for teachers to incorporate cannabis education into the curricula. REACH was developed by a 
multidisciplinary team of faculty advisors from the College of Nursing and the College of 
Pharmacy and Nutrition at the University of Saskatchewan, nursing students and a pharmacy 
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student following the legalization of cannabis in Canada. The faculty advisors believed that the 
previous teachings of abstinence and complete avoidance could no longer be applied in the 
context of cannabis legalization. Therefore, REACH was developed to give students the evidence-
based tools and knowledge they require to understand cannabis and make healthy, informed 
decisions.17 The program has since been approved as a curriculum resource for grades 7 and 9, by 
the Saskatchewan Ministry of Education.  
Along with the multidisciplinary team, youth were extensively involved in the 
development of the education material in the REACH program. The REACH nurse faculty 
advisors, nursing and pharmacy students spent the first three months of the 2019 winter semester 
developing the cannabis education program with the involvement of Grade 7 and 8 students at 
North Park Wilson School and St. Luke School along with Grade 9 students at Bishop James 
Mahoney High School and Tommy Douglas Collegiate. Feedback from students and teachers was 
received and incorporated throughout the development of the program.  
Following the development and refining of the program, REACH was added to the 
curriculum at the Saskatoon schools in the 2020 winter semester.17 As part of the Safe School 
Health Improvement Project (Safe SHIP) and School Health Initiative with Nursing Education 
(SHINE) program, nursing students are given the opportunity to participate in community 
outreach and education development. As a result, the administration of REACH in the winter 
2020 semester was via nursing students and the REACH nursing faculty coordinators. 
The REACH program consists of two modules: Module 1, which was developed for 
middle school students, and Module 2, which was developed for high school students.  These 
modules are consistent with the grade 7 and grade 9 Saskatchewan Ministry of Education’s health 
education curricular outcome, respectively.17  Each module is comprised of four lessons: (1) 
Introduction to Cannabis, (2) The Science of Cannabis, (3) Social Science Implications and (4) 
Peer Pressure, Decision Making and Harm Reduction.  Through these modules, REACH aims to 
help students approach the social context of cannabis use with adequate information on the 
substance and their health.  
Substance abuse continues to be a public health concern in Canada and globally. As a 
result of the recognition of adolescence as a critical phase in neuro- and social development, and 
the prevalence of cannabis use in Canadian youth, more focus needs to be put on educating youth 
and adolescents about the effects and regulations of cannabis. One step in this direction is the 
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development of standardized cannabis education curricula, such as REACH, and questionnaires 
that can help assess the learning and behaviours of students following these programs.  
3.8.  Approaches to the Assessment of Knowledge 
Following the introduction of public health and education initiatives, such as the REACH 
program, evaluations should be conducted to determine the efficacy of the initiative and guide 
future improvements. The ultimate goal of evaluating effectiveness of an educational program 
would be to assess changes in behaviour of the target audience (such as impact on cannabis use 
over time). Unfortunately, such assessments would require large sample sizes, a significant 
amount of time and resources, including a standardized method of implementation and way of 
controlling for confounders. Other methods of evaluation, which are easier to conduct, include the 
assessment of surrogate markers, such as behaviour intention or knowledge improvement.  
Questionnaires are a widely used method that allow researchers to explore the opinions, 
knowledge, attitudes, and behaviours of a large sample size due to their ease of distribution.109 
When developing a questionnaire for the purpose of a research objective, such as a knowledge 
assessment tool, the method of questionnaire development must be considered. Often, following a 
literature review by the researchers, a group of experts in the field of interest are gathered to select 
relevant items for the final questionnaire and provide feedback.110 However, the methods by 
which these experts reach a consensus on topics or items to include, along with details such as 
wording, structure and format of the questionnaire, can vary. Consensus development methods, 
such as the Delphi method, nominal group technique (NGT), and the consensus development 
conference (CDC), are often used by researchers when approaching experts for their input in the 
development of a questionnaire. Such methods will be covered in the following sections.  
3.8.1. Delphi Method: An Overview  
The Delphi method uses multiple iterations of questionnaires with the goal of informed 
consensus-building by experts on a topic of interest.111 The process is often carried out via 
emailing and online survey platforms. 111 On average, the Delphi method includes two to four 
iterations of the questionnaire with each round of the questionnaire building and improving on the 
previous round by incorporating the feedback of experts.111-113 The process is completed once 
consensus is reached and no novel ideas are generated by participants.112-115 Based on studies that 
have previously employed the Delphi method, consensus is defined as greater than 70% of 
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participants responding agree and strongly agree or as greater than 70% responding disagree and 
strongly disagree with a statement.17, 116-119 
The Delphi method is applied in the fields of natural and medical sciences or in 
policymaking, needs assessment and for finding practical solutions in applied studies.120 The 
selection of appropriate participants, also referred to as experts, in the Delphi method is 
considered the most important step in the process. In regard to the Delphi method, the term expert 
refers to an individual who has “i) knowledge and experience with the issues under investigation; 
ii) capacity and willingness to participate; iii) sufficient time to participate in the Delphi; and, iv) 
effective communication skills.”113,121 Although guidelines vary, the number of participants 
suggested for optimal idea generation and cost-effective timely participation in the Delphi method 
ranges from a minimum of 10 to an average upper limit of 50 to 100.111,112 Moreover, de Villiers 
et al., 122 suggest having 5 to 10 participants per discipline, while Delbecq et al., 123 recommend 
having the smallest number of participants possible that allows for a representative sample of 
different expert perspectives.  
The first round of the Delphi method is termed the exploration phase, which involves 
open-ended questions to allow for brainstorming by individual experts.113 The open-ended nature 
of the first round can also allow for greater expression of views and knowledge by experts, 
outside of what may be found in a literature review by the researcher.111 Therefore, the first round 
is a qualitative survey instrument. Following the first round and the identification of different 
themes that were notes, the subsequent phases of the Delphi method become more quantitative.111 
The next phase is called the evaluation phase and involves the development of second, third and 
fourth round questionnaires which can use different ranking systems, 111 such as a Likert scale, to 
determine expert’s opinion and feedback on the developing themes from the first round. The 
remaining rounds allow participants to see the changes made based on the comments from the 
previous round(s) and make further clarifications. As a result of this research design, the Delphi 
method allows for member checking which increased internal validity.124 Furthermore, continuous 
member checking has been noted to improve the reliability of results.113, 120, 121, 123, The multiple 
iterations allow participants time to reflect on their responses and adjust any feedback based on 
their reflections. 111 As a result, the validity of the data is enhanced.120 Also, due to the qualitative 
and quantitative nature of process, the Delphi method provides researchers with a more complete 
picture of the topic of interest. 111  
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The Delphi method has proved to be effective in facilitating discussion when there is a 
lack of previous knowledge or research on a phenomenon.120 As there is incomplete information 
on the public health and educational effects of cannabis legalization in Canadian students, this 
consensus method is beneficial. With the recent legalization of cannabis, the Canadian education 
system will see an increase in cannabis safety in its curriculum, while at the same time there 
continues to be a lack of standardization and evaluation techniques for this subject area. 
Therefore, the Delphi method is an appropriate starting point to gather expert opinion for the 
development of the cannabis knowledge assessment tool.  
The Delphi method allows for the aggregation of expert opinion through various 
platforms, such as series of face-to-face or telephone interviews, and mail, email or web-based 
questionnaires. However, the use of interviews is not common as one of the intentions of the 
Delphi method is to eliminate participants’ censorship, which could occur in the presence of 
researchers.125  
In addition to increasing researcher influence, interviews decrease the ability of 
researchers to maintain the confidentiality of each participant if interviews are overheard or 
overlap. Participants may have different opinions regarding a particular subject area (i.e. 
cannabis) and may feel uncomfortable sharing these opinions in groups or in questionnaires where 
they are identified.125–128 Group dynamics in focus groups or one-on-one interviews may also 
result in participants feeling silenced or timid due to personal preferences or professional 
standing. 125 Therefore, the requirement for confidentiality of experts and the use of online 
interaction in the Delphi method reduces response bias and conformity bias by eliminating group 
interaction, dominating opinions and identification.125, 126 For instance, if the Delphi method is 
performed through online interaction, participants are emailed individually to preserve 
confidentiality, limit access to identifiable information, restrict access to the participation list 
outside the research team, and avoid the presence of group pressure.112 
Administering the Delphi method online also eliminates face-to-face interactions between 
participants and the researcher, which allows ease of communication for the participant without 
being swayed by the researcher’s opinions.111 Other benefits of the online Delphi method include 
allowing the exchange of ideas without geographical restrictions, reduced expenses and time as 
compared to other methods and it reduces noise that would be present in data from group 
25 
processes.111 The online Delphi method also facilitates data management and analysis for 
researchers.111 Therefore, online platform questionnaires are preferred for the Delphi method.  
Due to the multiple iterations of the questionnaire required during the Delphi method and 
the time-consuming nature of answering each round, the process can be vulnerable to participant 
drop-out.111 Other reasons for drop out include participant disappointment with the outcomes of 
the rounds or distractions and time away between rounds,111 Also, while confidentiality is often a 
strength, it can also decrease ownership of ideas or increase the push of a participant’s agenda.111  
Although the Delphi method has weaknesses, the online approach has been found to 
minimize weaknesses, such as time demands on participants, while maximizing advantages, such 
as organizing the opinions of a variety of experts.111 With the novelty of cannabis education and 
the necessity for unbiased expert opinion in developing assessment tools, the Delphi method is a 
preferred way to gather opinion. Also, in contrast to key informant interviews and focus groups 
(which are alternative methods for gathering such opinion), the Delphi method allows for a cost-
effective and timely manner for gathering expert opinion.112 
3.8.2. Other Methods for Formal Consensus Development  
As previously mentioned, other methods of formal consensus development in addition to 
the Delphi method include NGT and CDC. NGT involves a one-time structured face-to-face 
meeting, often in a focus group setting.129 This study technique was developed to facilitate group 
discussion, decision making and therefore problem-solving.129 For instance, researchers will 
prepare predetermined questions to ask members of the focus group and lead group discussions. 
Due to the collaborative nature of the NGT, there is increased ownership of ideas that are being 
contributed to the research project. 129 Also, the face-to-face meetings allow researchers to build 
rapport with experts in the field, which is beneficial for the creation of subsequent research 
groups. 129   
NGTs involve small group sizes, usually of about 6-12 people.129 The focus group 
meeting will begin with an introduction and explanation of the meetings objective. Next, 
researchers allow for silent generation of ideas in which participants will note down or think of 
their answers to provided questions without consultation with others in the room. Ideas are the 
shared one by one, with no interruptions or individual debate occurring at this stage. Once every 
group member has shared their ideas, group discussion is started. Finally, the group will vote and 
rank the ideas that were presented until consensus is reached.129  
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Contrary to NTGs and the Delphi method, the CDC method provides public forum for 
discussion of the topic of interest.130 The panel members in the CDC process are both scientists 
and laypeople. Judgments are made by this group following the oral presentations of the evidence 
and literature findings by experts in the field in front of the public forum. These experts are not 
involved in the decision making. This method was developed by the US National Institutes of 
Health and is often used in healthcare decision making. 130  
According to James and Warren-Forward, 130 the decision between using the Delphi 
method, the NTG or the CDC relies on the purpose of the study along with the depth of 
knowledge available in the field of interest, along with the desired mode of distribution to 
participants, time, and cost. First, CDC is applicable where there is a greater availability of 
scientific evidence in the field while the Delphi method and NTG are used when there is a lack of 
previous evidence on the topic.130  
Issues that arise with NTG include scheduling conflicts when attempting to organize a 
meeting between busy professionals and the geographical challenges that may exist. The Delphi 
method is often carried out online and gives participants a timeframe to submit their responses, 
therefore geographical distance and busy schedules of participants is not often concern. Also, 
since NTG does not provide participants confidentiality and/or anonymity, there is a risk of 
conformity bias and dominance by certain group members. As a result, participants may not 
express their opinions as freely as they would during the Delphi method, especially about 
sensitive topics. Lastly, NTG involves only one session of group brainstorming and consensus 
development, whereas the Delphi method’s iterative rounds allow participants time for reflection 
and self-checking, thus improving validity of the Delphi method results. 
3.8.3. Questionnaire Formatting  
During the development of a questionnaire, questionnaire formatting involves determining 
the types of questions that are used along with the language that is used, the mode of 
questionnaire administration, the number of questions and the time required to complete the 
questionnaire. This allows researchers to create a questionnaire for their study’s needs while 
taking into account any limitations that must be addressed.131 Due to limited time and grading 
resources, researchers often use electronic-format questionnaires with close-ended questions, such 
as multiple-choice and ranking-style questions.  
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Multiple-true-false (MTF) questions are a format of multiple-choice question in which the 
stem and the options of a question are written like a multiple-choice question, however 
participants must mark each option listed under the stem as either true or false instead of selecting 
one answer. MTF questions allow participants to consider all of the response options for a 
question and mark each as true or false. Each item is then scored independently. As a result, MTF 
allows for a greater number of items to be tested, thus lengthening the questionnaire, which 
improves the questionnaire reliability.132, 133 Compared to MTF, single best answer MC 
questionnaires must have a greater number of questions to be representative of all the same 
items,134 which can be daunting for participants. Also, the greater complexity and decreased 
ability for cluing in MTF questions, when compared to MC questions, ensures the questionnaire is 
less likely to be subject to ceiling effects.132 Additionally, MTF items are a less complex version 
of multiple multiple-choice (MMC) questions, such as k-type questions which often ask, “choose 
all that apply”, as they award partial credit for partial knowledge. In comparison to MMC 
questions, MTF questions have a greater quantity of unique true-false patterns, thus also 
increasing their reliability.133 Therefore, MTF questions do not take much time for participants to 
complete while also allowing for a range of topics to be tested by administrators.132  
Although MTF questions also have a greater reliability in comparison to MC or MMC 
questions,131-134 there are also disadvantages to the MTF question format. For instance, 
participants can guess the right answer as there is a 50% chance of being right for each item.134 
For answers that are false, the student is being marked on knowing that an answer is incorrect 
instead of knowing the correct answer.134 As the format focuses on items that can be answered 
true or false, it may end up assessing trivial knowledge and may not encourage learning.134  
In addition to the types of questions, mode of administration and length of questionnaire, 
the language used in questionnaires is important for their target audience. In 2015, the 
Organisation for Economic Co-operation and Development (OECD) evaluated the performance of 
Canadian youth in reading through the Programme for International Student Assessment 
(PISA).116 The findings from the PISA study showed that Saskatchewan secondary school 
students performed lower than the Canadian average.116  To maximize readership and 
participation, it is important to monitor the readability of the questionnaire through methods such 
as the Flesch-Kincaid formula and the Simple Measure of Gobbledygook (SMOG) index. Both 
methods score text by reading grade-level. The Flesch-Kincaid formula bases the reading grade 
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score on the average number of words in a sentence and the average number of syllables in a 
word. The SMOG index evaluates 10 sentences in the beginning, middle and end of submitted 
material.135 Of these 30 sentences, the number of words that are 3 or more syllables are recorded 
and will correspond with the reading grade level.135 The SMOG index has been found to be useful 
in healthcare settings.135 Compared to the SMOG index, the Flesch-Kincaid formula on average 
has been found to predict 2-3 grade levels lower.135 Therefore, use of the two in combination is 
often recommended.  
 
4. HYPOTHESES 
1. There is a positive association between student participation in a cannabis education 
program and their cannabis knowledge assessment.  
2. There is a positive association between student participation in a cannabis education 
program and behavioural intention score. 
 
5. METHODS 
The research team consisted of a Master of Science student and four faculty members at 
the University of Saskatchewan. Among the faculty members, three were pharmacists while one 
was a biostatistician, and the group collectively held expertise in the areas of cannabis education, 
knowledge assessment and questionnaire development.  
Development and administration of the questionnaire was approved by the Research 
Ethics Board (BEH-130 and BEH-1670) along with the respective ethics boards of the Saskatoon 
Public School Board and the Saskatoon Catholic School Board. This chapter will cover the 
methods that were applied for questionnaire development, including explanations for each round 
of the Delphi method, and how the questionnaire was administered then analysed.  
5.1. Phase 1: Questionnaire Development 
To complete the first and second objectives a Cannabis Knowledge Assessment Tool (C-
KAT) and Behavioural Intention (BI) scale were developed with input from a group of 
stakeholders between the months of July 2019 to November 2019, prior to questionnaire testing 


















The Delphi method was used to develop the content for the C-KAT (Figure 2). For the 
Delphi method, the group of ‘experts’ included a purposive sample of healthcare professionals, 
policymakers, academics with an interest in cannabis, patients who used cannabis medically, and 
teenage students. In total, seven healthcare professionals, six policymakers, eight patients, six 
academics, and seven students were invited to participate. Hence, a total of 34 people were invited 
to share their perspectives regarding development of the C-KAT.  
 
Figure 2. Flowchart summary of the modified Delphi method used for the creation of the 
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A variety of perspectives was deemed to be important for identifying gaps in cannabis 
knowledge and developing the C-KAT.  The healthcare professionals who were invited included 
pharmacists, nurses, harm reduction coordinators, and physicians, based on their interest in 
cannabis research, their involvement in cannabis education, and/or their knowledge of cannabis’ 
effects on health. Policymakers who were invited to provide input into the questionnaire consisted 
of law enforcement personnel, cannabis authorized distributors, and advocates from relevant 
organizations (such as the Canadian Pharmacists Association) that had a close familiarity with the 
novel rules and regulations surrounding cannabis use. Members from Academia consisted of 
professors and researchers with a focus on cannabis research and/or educational development. 
While healthcare professionals, policymakers, and academics could contribute knowledge about 
mitigating risks and enhancing safety of cannabis use, we reasoned that a patient subset was 
necessary for providing context through the perspective of lived experience with both cannabis 
use and procurement, hence patient users were also invited to provide input. Finally, since the 
purpose of the C-KAT was to evaluate students’ knowledge of cannabis, it was important to invite 
students to participate in the Delphi method, and so students from elementary to postsecondary 
school were invited to participate.  
A brainstorming session was held amongst the researchers to generate a preliminary list of 
potential participants in the Delphi method. Each individual was contacted personally by a 
member of the research team to discuss the project, determine interest in participation and to 
ensure that the invited members had time to complete the process. Those interested were emailed 
individually (Appendix E). 
A Delphi method consisting of a series of web-based questionnaires was chosen as the 
preferred format for the creation of the knowledge assessment tool. These questionnaires were 
iterations of the same basic theme for the most part, depending on how questions scored. In this 
particular study separate questionnaires (or ‘rounds’) were used to gain consensus after feedback 
was incorporated into each subsequent ‘round’. Participants were asked to complete each round 
within a three-week time frame and an email reminder was sent approximately one to two weeks 
after each round of the questionnaire was sent (Appendix G). Individuals that did not respond by 
the deadline were sent a personal reminder via email or text from the study researcher (Appendix 
H). No incentives of any type were offered to the experts for taking part in the process, and 
completion of the questionnaires was taken as free and informed consent. 
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Each questionnaire was programmed into SurveyMonkey, an online survey development 
software licensed by the University of Saskatchewan and distributed to participants by email. The 
SurveyMonkey platform allowed researchers to maintain participant confidentiality and minimize 
costs while ensuring secure and timely responses. The identity of each participant and 
corresponding responses was known only to the research student and primary supervisor just in 
case follow up clarification was required, or if a person wished to withdraw their responses from 
the study. With each round, all responses were amalgamated, and the data were anonymized 
before sending out in the next iteration of the questionnaire, to help ensure confidentiality. An in-
depth explanation of the methods for each round of the Delphi method along with the 
development of the BI scale and the readability analysis of the questionnaire will be covered in 
the subsequent sections.  
5.1.1. Delphi Method: Round 1 
For Round 1, individuals who expressed an interest in participating after speaking to a 
research team member received a formal email invite to the study (Appendix F). This email 
provided an overview of the importance of the research project and development of the C-KAT 
for guiding education programs, along with an overview of the Delphi method. Within the email, 
there was a link to the first round of the questionnaire.  
Eleven open-ended questions were administered during the initial round, focusing on 
identifying the gaps in knowledge of the general public, the misconceptions of cannabis, and 
identifying target knowledge topics for students. The questions also explored opinion on the 
length of the questionnaire and how much time it took to complete.  
The questions used for this first iteration were self-created by the research team and were 
piloted on a graduate student from the College of Pharmacy and Nutrition, the School of Public 
Health and the College of Nursing at the University of Saskatchewan prior to disbursement to the 
Delphi participants. During the pilot phase the questions were revised for clarity and wording to 
avoid miscommunication and confusion, along with ensuring a variety of questions to allow for 
adequate exploration of the topic.  
Once participants completed Round 1 of the Delphi method for questionnaire 
development, the data were analyzed through qualitative coding and the creation of a codebook, 
using Microsoft Excel. Emergent coding, in which the code is developed from the data itself, was 
used to determine broad themes from the answers to the open-ended questions. As the research 
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student read through the responses from Round 1 of the Delphi method, themes that were 
emerging in each answer were highlighted and noted in the Microsoft Excel sheet. These themes 
were broken down into mutually exclusive categories, denoted as codes. For each new code that 
was identified, a definition was written down pertaining to the theme of the code to allow 
differentiation between codes. It was tallied each time a participant’s answer mentioned an 
existing code, and if a novel theme was mentioned in an answer a new code was created until all 
themes were covered. The number of times each code was mentioned was summed for each 
question. All data analysis was performed by the research student and rechecked and verified by 
the research team. 
Since it was challenging to determine and condense the data’s major themes simply by 
looking at the codebook, principal component analysis (PCA) was performed with the codes from 
Q1, What essential information should the general public know about cannabis. Each of the 17 
codes from the 24 participants were treated as variables and the PCA helped to clarify what 
content was important to include on the knowledge assessment questionnaire.  
PCA is a dimensionality reduction technique that allows researchers to identify a new 
component that is a combination of the old, larger set of variables.61 As a result of the feature 
extraction abilities of PCA, a large data set, such as our 17 variables, is transformed into a smaller 
set of variables (principal components) that still contain most of the information from the large 
set.   
A total of three components were deducted from the PCA. For each component, a 
minimum of two variables were used with the highest correlation. For component 1 and 2 there 
was a sufficient number of variables with a correlation greater than 0.6 (four variables and three 
variables, respectively). However, for component 3, the two highest positive correlation variables 
used were below 0.6. Therefore, the 17 codes from Q1 were reduced to 3 components that 
encompassed 9 codes with the greatest correlations.  The three principal components that were 
obtained from the PCA for Q1 guided the content for the knowledge questionnaire.   
5.1.2. Delphi Method: Round 2, 3 and 4 
The experts who completed each round were invited to participate in each subsequent 
questionnaire (Appendix F). The questions used in each subsequent iteration were modified based 
on participant feedback and consensus, and the questionnaires became increasingly specific 
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following each round of collection and analysis to generate and refine the questions to be used in 
the final version of the C-KAT.  
To begin, based on the factors derived from the PCA in Round 1 and guided by 
participant’s answers in Round 1, multiple-choice questions were developed by the research 
team. These multiple-choice questions were presented back to the expert panel, and 
participants were asked to comment on whether they believed the question should be included 
in the final questionnaire, and to provide suggestions for improvement if they saw any. 
Participants were asked during Round 2, 3 and 4 of the Delphi process if they strongly agree, 
agree, felt neutral, disagree or strongly disagree with each question being asked based on a 5-
point Likert scale. 
Survey responses were collected and recorded following each round in a Microsoft 
Excel spreadsheet. For each question, the number of participants who answered, strongly 
disagree, disagree, neutral, agree or strongly agree were noted. Comments made by 
participants were individually addressed and modifications were made to the multiple-choice 
questions based on expert suggestions. The revised questions were then presented back to the 
group during each subsequent round in the Delphi method. If a question received a percent 
agreement of less than 70%, meaning less than 70% of participants selected strongly agree or 
agree, the question was removed or reworded. As mentioned previously, 70% agreement for 
consensus was found to be appropriate by previous studies using the Delphi method. 17,114–117  
Round 3 and 4 allowed participants to see the changes made based on the comments from the 
previous round and make further clarifications. After Round 4, > 70% consensus was 
achieved on all the questions and no further rounds of changes to the questionnaire were 
made.  
Following each iteration of the Delphi method, the questionnaire format of the C-KAT 
was determined through pilot work with three students, two in grade 7 and one in high school. 
These three students helped researchers identify appropriate questionnaire format between true 
false (TF), multiple choice (MC), multiple-multiple choice (MMC) and multiple true false (MTF). 
After each iteration of the Delphi method, the updated questionnaire was assessed by the same 
three students.  
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5.1.3. BI Scale Development  
The BI scale was drafted by the research team based on the codebook from Round 1, 
question 6, of the Delphi method which asked participants, what essential information should 
youth, (in particular, grades 7-12) know about cannabis? This question and the answers 
associated with it were chosen as it gave researchers a good starting point for topics to cover in 
the BI scale based on expert opinion of the Delphi method participants, in order to try and predict 
future behaviour as it pertains to cannabis use. Based on the answers, the BI scale draft focused 
on questions regarding the effects of cannabis, the social consequences of cannabis use and test-
taker’s perceptions of cannabis use prior to the legal age of consumption.  
Once the initial version of the BI scale was developed by the student researcher and an 
expert in questionnaire development, it was distributed to six educators and three students by 
email for content review and input. Educators included individuals with expertise in assessment, 
questionnaire development, healthcare and biostatistics. An initial email was sent to the six 
educators and three students to ask for their assistance in reviewing the BI scale draft, with 
follow-up emails being sent to clarify their suggestions or ask for further input. After changes 
were made based on the suggestions, the researcher and the questionnaire development expert met 
to make final changes to wording and formatting.  
Following several discussions between educators based on the number of scale points, the 
5-point Likert-based scale was chosen to be able to provide participants with an adequate number 
of options to state their degree of agreement or disagreement while remaining manageable.69 The 
scale has all five points labelled as it was found that end-point labelling may result in avoidance 
of the extremes and increase likelihood of answers concentrated in the middle of the scale.69 Next, 
a neutral option was included to avoid a forced choice. As a result, students were given the option 
to keep their opinion undisclosed should they feel uncomfortable or remain indifferent on certain 
statements. Double-barrelled questions asking about two variables at one time were avoided to 
decrease confusion or answers that addressed only one part of the question.69 Finally, a brief 
explanation and example section were included prior to the first BI scale question to show 
students an example of this questionnaire and response style.  
5.1.4. Readability Analysis 
Following the completion of Round 2, Round 3 and Round 4 and the completion of the BI 
scale, the questionnaire was tested for readability. In order to attain an 8th grade reading level, the 
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questionnaire was revised subsequently to the Flesch-Kincaid formula and the SMOG index. The 
Flesch-Kincaid Grade Level is determined with a formula using the average sentence length and 
the average syllables per word,72 while the SMOG index assesses the number of complex words 
in 30 sentences from the beginning, middle and end of the text.72 Both the Flesch-Kincaid Grade 
Level and the SMOG index are the most commonly used readability tests.73 All readability tests 
were performed on free online software at www.readabilityformulas.com 
5.2. Phase 2: Questionnaire Testing 
The third objective of this study was to administer the questionnaire to the same cohort of 
students before and after their participation in a cannabis education program. For the purposes of 
this study, seven schools that had recently implemented the REACH program were purposely 
chosen to test the validity of the questionnaire. These schools represented various school grades, 
both public and Catholic schools, and geography and demographics. Beginning in February of 
2020, nursing students and faculty began delivering the REACH program to select Grade 7 
classes at Brunskill Public School, North Park Wilson Public School, St. Lorenzo Ruiz Catholic 
School, St. Luke Catholic School, and George Vanier Catholic School along with Grade 9 classes 
at Tommy Douglas Collegiate and Bishop James Mahoney Catholic School.  Grades 7 and 9 were 
chosen because they represented time points in elementary and high school when students are 
likely to be introduced to cannabis and were the targets of the REACH program. Notably the 
REACH program is also aligned with the Saskatchewan Ministry of Education’s curriculum 
outcomes for these grades. 
In order to participate in the study, written consent had to be provided by the students’ 
parents or legal guardians. Prior to beginning the REACH program, the research student, a faculty 
member, and the nursing students held a brief introductory session about what the study was, and 
the consent process. An envelope was handed out to each student in class, which contained all 
information necessary for the consent process. The package included a consent letter for the 
parents or legal guardians detailing the research and contact information of the researchers 
(Appendix A). This was to be signed and sent back to school with the students. Additionally, it 
contained a watermarked copy of the assent form which the students were given a copy of, so that 
the parents could see what the students read as well (Appendix B). The assent form allowed 
students who were under the legal age of consent to be informed about the study and agree to 
participating. All students received the REACH education program as part of the school 
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curriculum, however only those students with signed consent forms were allowed to complete the 
questionnaire and participate in the study. Additionally, even if the parents or legal guardians 
consented to their children participating in the study, the students were made aware that 
participation was optional and they could chose to not participate if desired. Prior to taking the 
pre-and post-test, the students read the assent forms that described the study.   
5.2.1. Pre-test and Post-test 
A pre-test, post-test design was carried out in which the same participants were tested each 
time. Scheduling of the pre- and post-test for all schools was determined by the homeroom 
teacher’s schedule, the REACH program coordinators schedule and the researcher’s availability. 
Each pre-test and post-test was administered by the researcher. For Brunskill Public School and 
Tommy Douglas Collegiate, the pre-test was administered on the same day as the beginning of the 
REACH program, prior to the first lesson. The pre-test was administered a week and half prior to 
the first lesson at St. Lorenzo Ruiz Catholic School and one day prior to the first lesson at Bishop 
James Mahoney Catholic School.  
On the morning of the pre-test, the researcher attended the scheduled class time and 
collected all the consent forms which were returned to the home-room teacher or nursing students. 
The names of students with signed consent forms were called out and students picked up an 
envelope which included the assent letter and a watermarked copy of the consent letter, along 
with the questionnaire (Appendix C, Appendix E). The researcher reviewed the study details to 
ensure students understood the research, the questionnaire instructions, and ensured the students 
that anonymity would be maintained during the process. To ensure anonymity, students were 
instructed to use a unique codename consisting of a word and/or number (or any combination) of 
their choice that only they would know, so that their pre-test could be matched to their post-test. 
This explanation of the study took 5 minutes, and completion of the pre-test took approximately 
15 to 20 minutes. If students had questions during the completion of the questionnaire, they were 
instructed to raise their hand and the researcher would then answer their question. The 
schoolteachers were not involved with the questionnaire process; all questionnaires and consent 
forms were collected by the researcher.  
Once the entire REACH program was delivered, the post-tests could be performed. For 
Brunskill School Public School and Bishop James Mahoney Catholic School, these post-tests  
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were performed one week following the completion of their last REACH lesson. The post-test 
administration process was similar to the pre-test whereby a study description was given by the 
researcher, and the post-test was handed out to students for whom had completed the pre-test after 
a consent form was obtained. The students were asked to write the same codename on their 
questionnaire that they used for their pre-test. This took 20 minutes.  
At Tommy Douglas Collegiate, students received their post-test immediately following 
their last lesson. For St. Lorenzo Ruiz Catholic School, the post-test occurred the day following 
their last REACH lesson. Unfortunately, the post-test results could not be obtained for the other 
participating schools, as data collection was interrupted due to COVID-19.   
In the case that a student wrote a different codename on their pre-test and post-test, the 
unmatched questionnaires were removed from the study.  
5.2.2. Data Analysis  
Immediately after the pre-tests were performed, the researcher scored the C-KAT portion 
of the questionnaire and each student was given a grade out of 64 (i.e. there were 64 discrete 
answers). One mark was deducted from the total score for each item that was answered wrong on 
the C-KAT. The same process occurred following the completion of the post-test by the students. 
Once the post-tests were scored, the questionnaires were matched to a pre-test based on the 
codenames, therefore each student had a score for their pre-test and their post-test on the C-KAT. 
Students who were present for the pre-test but absent for the post-test had their questionnaire 
removed to ensure each individual had a complete data set.  
For scoring of the BI scale, the corresponding numerical response to each Likert scale 
question was noted in IBM SPSS (version 26). If a student responded that they strongly agree, a 
score of 1 was noted, for agree a score of 2 was noted, while neutral, disagree, strongly disagree 
received a score of 3, 4 or 5, respectively. Four questions (Q17, Q20, Q26 and Q27 on the full 
questionnaire, corresponding to Q1, Q4, Q10, Q11 on the BI scale) on the BI scale answers were 
reverse scored using the recode variable function in SPSS to allow for consistency during 
reporting. As a result, favourable behaviours were indicated by answers at the higher end of the 
Likert-based scale while those at the lower end of the scale indicated unfavourable behaviour.  
Following the scoring of the questionnaires, the results were entered into and analyzed 
using IBM SPSS (version 26). The researcher reviewed the score entries twice to ensure all 
scoring was inputted correctly. Demographics, including school, gender and grade for each data 
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set were recorded. Match-paired t-tests were performed on SPSS for each dependent data set to 
test the null hypothesis that the means of the pre- and post- tests are the same against the 
alternative hypotheses that the post-test scores are greater. For sample sizes < 25, such as Other 
Genders and Tommy Douglas Collegiate, a p-value was not recorded as this sample size does not 
satisfy the assumptions for a match paired t-test. A significance level of 0.05 was used as this is a 
reasonable cut off for statistical significance in this study and indicates that there is a 5% risk of 




6.1. Phase 1: Questionnaire Development  
6.1.1. Delphi Method: Round 1 
The first round of the Delphi survey consisted of open-ended questions and was analysed 
using emergent and open coding. From the 34 experts emailed, 24 participated, resulting in a 
70.6% response rate. The 24 participants consisted of six health care professionals, five 
policymakers, four patients, three academics with an interest in cannabis, and six students.  
Following the coding of Round 1, a PCA was completed for the codes in Q1, What 
essential information should the general public know about cannabis (Figure 3). The first 
principal component was strongly correlated with 4 of the original 17 codes. As shown in Figure 
3, social consequences, substance misuse, familial support and cultural links all had a correlation 
of 0.985. These themes revolved around effects on the individual including social exclusion and 
how to address cannabis use or overuse within a family and the cultural importance of cannabis to 
some. Therefore, this component can be viewed as impact of cannabis on the individual. The 
second component included 3 of the 17 codes as the variables with the highest correlation: gaps in 
scientific evidence, different components, and contraindications. This component was grouped as 
general information about cannabis as the themes involved scientific knowledge of cannabis and 
its side effects. The third component was grouped as cannabis harm reduction as the 2 themes, 
regulation, and harm reduction techniques, related to regulations and precautions to take to avoid 
harm when using cannabis. 
6.1.1.1.  Determining Questionnaire Format 
Following the analysis of Round 1, the draft questionnaire was piloted on two grade 7 
students and one high school student to check the difficulty of content and determine the format 
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of the questions, such as single TF, MC, MMC or MTF. The cohort of students indicated that 
single true and false questions were too easy. However, students were indifferent to whether or 
not the multiple-choice question had more than one correct answer, as in the MTF format, as long 
as the format of the questions remained the same throughout the questionnaire. MTF was used for 
the C-KAT as a result of the students’ feedback along with previous work showing that the 
benefits of the MTF format. 
 
Figure 3. Principal component analysis with 3 component extraction performed based on the 
qualitative coding of answers from Round 1, Q1. Bolded items represent the variables from the 
larger set that were incorporated into the new variables of impact of cannabis on the individual 
(component 1), general information about cannabis (component 2), and cannabis harm reduction 
(component 3).  
  
6.1.2. Delphi Method: Round 2 
The second round of the Delphi survey consisted of 20 questions with Likert-based scales 
and a final question asking for the participant’s first name and last initial. The 20 questions 
addressed the three main factors derived from the Principal Component Analysis: 1) general 
information about cannabis, 2) impact of cannabis on the individual, and 3) cannabis harm 
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reduction. There were 7 questions related to factor 1, 8 questions related to factor 2, and 5 
questions related to factor 3.  
From the 24 experts who responded in Round 1, 21 participated in Round 2 (87.5% 
participant retention from Round 1). The 21 participants included six health care professionals, 
four policymakers, three patients, three academics in the field, and five students. 
Each of the questions were analyzed to determine agreement amongst the participants. 
From the 20 questions, four questions had percent agreements lower than 70% (Table 1). The 
stems of these four questions included: (Q4) Which of the following statements are TRUE 
regarding the different forms of cannabis?, (Q6) Which of the following are TRUE regarding 
THC and CBD?, (Q7) Which of the following is TRUE regarding the potency of cannabis, and 
(Q9) What are some potential long-term effects of using cannabis? Q4 and Q6 received the lowest 
percent agreement (63.64%). The majority of comments for Q4 were in regard to wording, such 
as the use of the word effective, and the difficulty of the content; however, comments also 
mentioned the importance of such questions regarding the effects of different forms of cannabis. 
Participants indicated that Q7 may be difficult for younger individuals and the general public and 
may not give accurate insight into cannabis knowledge levels. Q6 and Q9 both received a 68.18 
percent agreement, with comments for Q6 suggesting that the question should address one topic at 
a time, instead of both the euphoric effects (A and B) and medical uses (C and D) of cannabis. 
The comments for Q9 suggested removing the word curing and replacing it with treating along 
with rewording some of the answers. All other questions received a percent agreement of 70% or 
greater.  
Additional comments from Round 2 on the other questions suggested that participants 
were in agreement that questions regarding the misconceptions of cannabis (Q1), terpenes and 
cannabinoids (Q2, Q6), cannabis potencies (Q4), harmful effects of cannabis (Q8, Q9, Q11), 
cannabis use below the age of 25 (such as Q12), along with cannabis and travel (such as Q18) are 
necessary topics for the final C-KAT.  
Other comments also suggested that wording should be less complex. For instance, the 
mention of phrases such as dose, onset of effect, harm reduction strategies, and adverse 
consequence were criticized. Moreover, participants suggested changing vague words, such as 
curative (Q1) and effective (Q4). Subsequent comments included changing wording to improve 
the inclusivity of the C-KAT’s language. For instance, it was suggested that Q5. B) A mother who 
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is breastfeeding be changed to Someone who is breastfeeding. Uniformity of wording in questions 
was also mentioned. For example, in Q12 (It is important to delay cannabis use until after the age 
of 25 because) it was proposed that the phrase age 25 was repeated instead of this age in the 
question answers. Experts also recommended that consistent terminology should be used to refer 
to cannabis dispensaries. Furthermore, the mention of eating was changed to ingesting (Q8) to 
include other oral routes such as oils or capsules, while the term medical license was replaced 
with medical authorization (Q13) for accuracy. 
 
Table 1.  Percent agreement based on percent of experts who agree and strongly agree with the 




(% Strongly Agree + % Agree) 
Round 2 Round 3 Round 4 
1 86.37 71.43 100 
2 72.72 90.48 88.89 
3 81.82 90.48 94.45 
4 63.64 90.47 88.88 
5 81.81 95.24 83.33 
6 68.18 90.48 88.89 
7 63.64 90.48 88.89 
8 72.73 90.48 94.45 
9 68.18 95.24 77.77 
10 95.45 80.96 83.34 
11 86.36 95.24 94.44 
12 77.27 80.95 100 
13 72.73 90.48 94.44 
14 77.27 85.72 88.89 
15 72.73 95.24 88.89 
16 95.46 85.72 72.22 
17 95.46   
18 90.91   
19 72.73   
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6.1.3. Delphi Method: Round 3 
Round 3 of the Delphi survey consisted of 16 questions with Likert-based scales. The four 
questions from Round 2 of the Delphi method that received less than 70% agreement (Q4, Q6, 
Q7, and Q9) were removed from this questionnaire, and similar themes, such as information about 
the components of cannabis and long-term effects of cannabis use, were incorporated into other 
questions. Each of the 16 Likert-scale based questions in Round 3 also allowed comments to be 
made by participants following their answer. All 21 experts who participated in Round 2 
participated in Round 3 (100% participant retention from Round 2, 87.5% participant retention 
from Round 1).  
All 16 questions in Round 3 received a 70% agreement or higher (Table 1), thus each 
question was further analysed based on comments. Q1, which statements are TRUE regarding 
cannabis, received a much lower approval score (71.43%) than all other questions (80.95-
95.24%).  
Comments from different participants in Round 3 suggested making each question focused 
on one concept. For instance, Q1 included answers based on terminology as well as cannabis 
ingredients. Q2 (Which statements are TRUE regarding THC (tetrahydrocannabinol) and CBD 
(cannabidiol)) assessed various concepts, while Q3 (Which statements about cannabis are TRUE) 
assessed the safety, use and evidence for cannabis. Furthermore, an expert mentioned that 
cannabis is promoted for use under the age of 25 for individuals suffering from epilepsy and thus 
Q6, why is it important to AVOID using cannabis before the age of 25, was recommended to be 
rephrased to address such exceptions.  
Q13, which statements are TRUE regarding cannabis laws, is based on Saskatchewan-
specific regulations, and it was recommended to instead address Canada-wide regulations, to 
decrease the limitations of the C-KAT. Further content-based changes included the range of hours 
recommended following cannabis use for driving in Q14.A (Avoid driving for at least eight hours 
after taking it), whereby one expert mentioned that literature often mentions a minimum of six 
hours prior to using a motor vehicle. Other suggestions also included removing questions that 
may need to be constantly updated due to ongoing research, such as Q8.  
20 81.82   
43 
In addition to the abovementioned content changes, experts also suggested changes to the 
wording of some questions and answers. Experts proposed changing vague words such as works 
in Q4.C (what works for one person may not work for another) and the vague phrase potentially 
effective in the stem of Q8 (cannabis has been shown to be potentially effective for treating which 
medical conditions). Other wording changes included changing prescription for medical cannabis 
to medical authorization in Q12.A (you need a prescription for medical cannabis but not for 
recreational cannabis). Grammatical changes were also suggested to make the terminology of 
answers more consistent, such as removing the terms because in Q6.A and Q6.C.  
6.1.4. Delphi Method: Round 4 
From the 21 participants in Round 2 and Round 3, 18 experts participated in Round 4 
(85.7% participant retention from Round 2 and 3, 75% retention from Round 1). Of these 18 
experts there were six health care professionals, three policymakers, three patients, two academics 
in the field, and four students.   
Each question received a 70 percent agreement or higher (Table 1), and all 
comments/feedback provided were in regard to wording or grammatical changes. Q1 (which 
statements are TRUE regarding the compounds (ingredients) in cannabis) and Q12 (which 
statements are TRUE regarding the regulation of cannabis) received 100% agreement. All other 
questions received a minimum of 83.33% agreement except for Q9 (in someone using cannabis, 
which of the following ways may be harmful to their lungs) and Q16 (if you want reliable 
information about cannabis, where should you seek out information) which received 77.77% and 
72.22%, respectively.  
Following a revision of the wording in the C-KAT based on the comments from Round 4, 
the questionnaire was finalized and received a Flesch-Kincaid Grade Level of 6.3, along with a 
SMOG index score of 7.6 (Table 2).  The final version of the C-KAT (with answers) can be found 
in Appendix 2 and 3.  
Table 2. Flesch-Kincaid Grade Level and SMOG index score for the Cannabis Knowledge 
Assessment Tool and Behavioural Intention Scale, obtained from www.readabilityformulas.com.  
 
Flesch-Kincaid Grade Level SMOG Index Score 
C-KAT 6.3 7.6 
BI Scale 7.2 8 
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6.1.5. Behavioural Intention Scale Development 
Following the development of the C-KAT through the Delphi method, the researchers 
consulted educators and students on the development of a behavioural intention (BI) scale. First, 
the draft questions developed by the research student and expert in questionnaire development 
were based on the most mentioned codes from Round 1, Q6, What essential information should 
youth, (in particular, grades 7-12) know about cannabis? Codes included physiological 
consequences, youth-specific consequences, harm reduction techniques, regulation and legality, 
dealing with peer pressure and social consequences. 
With respect to formatting of the questions, initially the scale was a 7-point Likert scale 
because of the inclusion of options in between strongly- and somewhat- agree or disagree as well 
as a neutral option. The neutral option was kept as some students may have no opinion or be 
indifferent toward a question and the lack of neutral option would force an opinion that may not 
be genuine. After discussion and debate it was decided that a 5-point Likert-scale with descriptors 
placed on top, would be most simple and easier for students to understand. 
 
Figure 4. The Behavioural Intention Scale  
In the second part of this questionnaire, we have a few statements for you to read and 
indicate on a scale from 1 to 6 if you agree or disagree.  
For example: 
If you strongly agree, meaning you agree with the statement a lot, circle 1. 
Strongly              Agree                 Neutral               Disagree                Strongly         
  Agree                                                                                                     Disagree 
                  1                         2                          3                          4                            5                       
If you feel neutral, meaning you neither agree nor disagree, circle 3.  
Strongly              Agree                 Neutral               Disagree                Strongly         
  Agree                                                                                                     Disagree 
                  1                         2                          3                          4                            5                       
If you strongly disagree, meaning you disagree with the statement a lot, circle 5.  
Strongly              Agree                 Neutral               Disagree                Strongly         
  Agree                                                                                                     Disagree 
                  1                         2                          3                          4                            5                       
      
Please circle the number that best describes your opinion. Please only circle one number for 
each question. 
 
17. Using cannabis will negatively affect my health 
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Strongly              Agree                 Neutral               Disagree                Strongly         
  Agree                                                                                                     Disagree 
                  1                         2                          3                          4                            5                       
 
18. Using cannabis will give me a fun “high” 
 
Strongly              Agree                 Neutral               Disagree                Strongly         
  Agree                                                                                                     Disagree 
                  1                         2                          3                          4                            5                       
 
19. I am curious about what it feels like to try cannabis 
 
Strongly              Agree                 Neutral               Disagree                Strongly         
  Agree                                                                                                     Disagree 
                  1                         2                          3                          4                            5                       
 
20. Using cannabis will negatively affect my future (for example, sports, jobs, school) 
 
Strongly              Agree                 Neutral               Disagree                Strongly         
  Agree                                                                                                     Disagree 
                  1                         2                          3                          4                            5                       
  
21. Most people who are important to me think using cannabis is okay   
 
Strongly              Agree                 Neutral               Disagree                Strongly         
  Agree                                                                                                     Disagree 
                  1                         2                          3                          4                            5                       
  
22. I have friends who use cannabis 
 
Strongly              Agree                 Neutral               Disagree                Strongly         
  Agree                                                                                                     Disagree 
                  1                         2                          3                          4                            5                       
23. I have family members who use cannabis 
 
Strongly              Agree                 Neutral               Disagree                Strongly         
  Agree                                                                                                     Disagree 
                  1                         2                          3                          4                            5                       
 
24. I will consider using cannabis to impress my friend(s) 
 
Strongly              Agree                 Neutral               Disagree                Strongly         
  Agree                                                                                                     Disagree 
                  1                         2                          3                          4                            5                       
 
25. I will consider using cannabis to gain a sense of independence from my parents 
  
Strongly              Agree                 Neutral               Disagree                Strongly         
  Agree                                                                                                     Disagree 
                  1                         2                          3                          4                            5                       
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26. My decision to use cannabis is up to me  
 
Strongly              Agree                 Neutral               Disagree                Strongly         
  Agree                                                                                                     Disagree 
                  1                         2                          3                          4                            5                       
 
27. I have a trusted adult I can talk to about cannabis  
 
Strongly              Agree                 Neutral               Disagree                Strongly         
  Agree                                                                                                     Disagree 
                  1                         2                          3                          4                            5                       
 
28. I will consider using cannabis before the legal age in my province 
 
Strongly              Agree                 Neutral               Disagree                Strongly         
  Agree                                                                                                     Disagree 
                  1                         2                          3                          4                            5                       
 
Three of the six educators commented on changes regarding wording of the BI scale. For 
instance, one expert suggested using direct language, instead of a passive voice as the passive 
voice suggests thinking about something in the future, and to maintain consistency (e.g. using 
cannabis would negatively affect my future was changed to: using cannabis will negatively affect 
my health). Wording was also changed from questions which were Saskatchewan-specific to more 
general in order to be able to be used more broadly. For instance, the question I would consider 
using cannabis before the age of 19 was changed to I will consider using cannabis before the 
legal age in my province. Also, it was suggested by two experts that details should be given for 
the question using cannabis will negatively affect my future. As a result, examples were added to 
the question.  
Educators also suggested including questions regarding cannabis use in the student’s 
environment, such as I have family members who use cannabis and their social support systems, 
such as I have a trusted adult I can talk to about cannabis. Other aspects that were mentioned by 
two experts were the aspects of peer pressure or independence-seeking that adolescents may face. 
Therefore, an expert suggested adding questions such as I will consider using cannabis to impress 
my friend(s), I will consider using cannabis to gain a sense of independence from my parents, and 
my decision to use cannabis is up to me. Along with the themes of environment and peer pressure, 
the question most people who are important to me think using cannabis is okay and I have friends 
who use cannabis were suggested to be included.  
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The final BI scale (Figure 4) includes brief instructions prior to the start of the survey and 
11 questions using a 5-point Likert scale. The BI scale attained a Flesch-Kincaid Grade Level of 
7.2, along with a SMOG index score of 8 (Table 2).   
6.2. Phase 2: Questionnaire Testing 
The pre-test was administered to 413 students in seven schools in Saskatoon, SK (Table 
3). The post-test could not be completed in 3 schools due to COVID-19 interruption. Therefore, 
the post-test was completed by 138 students in 4 classrooms; However, six pre-tests and post-tests 
had unmatched codenames and were therefore removed resulting in 132 total participants (32% 
completion rate overall).  
Of the 132 students who completed the pre- and post-test, 84 identified as female, 46 
identified as male and 2 identified as other. Of these 84 females, 40 were in grade 7 (54.8% of the 
grade 7 students) and 44 were in grade 9 (74.6% of the grade 9 students). Of the 46 males, 31 
were in grade 7 (42.5% of the grade 7 students) and 15 were in grade 9 (25.4% of grade 9 
students). Both students who identified as other were in grade 7 (2.7% of the grade 7 students).  
 
Table 3. Demographics of questionnaire respondents.  
 




































































Note: (%) in greyed area represent the percentage of the specific demographic within each school. 
6.2.1. Matched-Paired T-Tests: Cannabis Knowledge Assessment Tool 
Results comparing the overall C-KAT scores in those students who completed a pre-test 
and post-test showed that student scores increased from the pre-test (mean=46.17, SD=5.46), to 
the post-test (mean=50.71, SD=4.58). At the α=0.05 level of significance, there was a statistically 
significant change in knowledge between the pre-test and post-test (p-value <0.05) (Table 4). 
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6.2.1.1.  Comparison Between Grade 7 and 9 
C-KAT scores for grade 9 students increased from the pre-test (mean=48.76, SD=4.66),  
to the post-test (mean=52.51, SD=3.94) (p-value <0.05). For the grade 7 students, pre-test scores 
for knowledge (mean=44.07, SD=5.17) also increased during the post-test (mean=49.26, 
SD=4.56) (p-value <0.05). At the α=0.05 level of significance, there was a statistically significant 
change in knowledge between the pre-test and post-test in grade 7 and grade 9 students (p-value 
<0.05) (Table 4). 
6.2.1.2.  Comparison Between Genders 
A sub-analysis was performed whereby participants were stratified by gender.   
The mean scores increased for all gender identifications in the pre- and post-tests [pre-test: female 
students (mean=45.57, SD=5.54), male students (mean=47.13, SD=5.25) and students identifying 
as other (mean=49, SD=5.66) ; post-test; female students (mean=50.70, SD=4.51) (p-value 
<0.05), male students (mean=50.65, SD=4.79)( p-value <0.05) and students identifying as other 
(mean=52.50, SD=3.54) (Table 4). The increase in scores for both males and females were 
statistically significant (p-value<0.05). The sample size for students who did not identify as male 
or female (n=2) was too low for any statistical analysis (Table 4). 
6.2.1.3. Comparison Between Schools 
An analysis was performed to determine the mean changes in pre and post test scores for 
each school. Due to a sample size less than 25, statistical analysis could not be completed on the 
CKAT scores for Tommy Douglas Collegiate students. The scores for students at Bishop James 
Mahoney Catholic School increased from the pre-test (mean=49.37, SD=4.91) to the post-test 
(mean=53.17, SD=3.67) (p-value <0.05). The scores for students at Brunskill Public School 
improved from the pre-test (mean=45.24, SD=5.85) to the post-test (mean=49.48, SD=5.08) (p-
value <0.05). The scores for students at St. Lorenzo Ruiz Catholic School improved from the pre-
test mean of 43.30 (SD=4.58) to the post-test mean of 49.11 (SD=4.25) (p-value <0.05) (Table 4). 
The increase in scores were statistically significant for all 4 schools (p-value <0.05) (Table 4). 
 
Table 4. Match-paired t-test for the C-KAT score before and after the REACH  program 












44.07 (5.17) 49.26 (4.56) 5.19 (4.32) <0.05 
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6.2.2. Match-Paired T-Tests: Behavioural Intention Scale  
The overall mean pre-test for all 132 participants was 48.90 (SD=7.49) and the mean 
overall post-test was 48.49 (SD=7.61), indicating that there was no significant change from pre-
test to post test. No significant changes were noted for any of the demographics, with the 
exception of female students (p-value <0.05) (Table 5).  
 
Table 5. Match-paired t-test for the total BI score before and after the REACH education program 












51.03 (5.49) 50.62 (5.78) -0.41 (3.28) 0.144 
Grade 9 
(n=59) 
46.27 (8.74) 45.85 (8.74) -0.42 (4.19) 0.221 
Female 
(n=84) 
48.94 (7.49) 48.18 (7.85) -0.76 (4.11) <0.05 
Male 
(n=46) 
49.09 (7.59) 49.26 (7.21) 0.17 (2.85) 0.341 
Other Genders 
(n=2) 
43.00 (4.24) 43.50 (6.36) 0.50 (2.12)  
Grade 9 
(n=59) 
48.76 (4.66) 52.51 (3.94) 3.75 (4.26) <0.05 
Female 
(n=84) 
45.57 (5.54) 50.70 (4.51) 5.13 (4.62) <0.05 
Male 
(n=46) 
47.13 (5.25) 50.65 (4.79) 3.52 (3.67) <0.05 
Other Genders 
(n=2) 













45.24 (5.85) 49.48 (5.08) 4.24 (3.63) <0.05 
St. Lorenzo Ruiz 
Catholic School 
(n=44) 
43.30 (4.58) 49.11 (4.25) 5.82 (4.65) <0.05 
Total 
(n=132) 














53.00 (4.62) 52.90 (4.86) -0.10 (2.11)  0.397 
St. Lorenzo Ruiz 
Catholic School 
(n=44) 
49.73 (5.68) 49.11 (5.89) -0.61 (3.88) 0.150 
Total 
(n=132) 
48.90 (7.49) 48.49 (7.61) 0.42 (3.70) 0.099 
 
Matched-paired t-test were performed for each individual question of the BI scale (Table 
6) and statistical differences were found only three of the items. The scores for I am curious about 
what it feels like to try cannabis (p-value <0.05) and I have family members who use cannabis 
decreased after the REACH program (p-value <0.05), while the scores for Using cannabis will 
negatively affect my future (for example, sports, jobs, school) increased (p-value <0.05) (Table 6). 
 
Table 6.  Match-paired t-test for the mean change in score of each BI scale question, for all 
participants (n=132).    
Variable 
Mean Change (SD) 
(n=132) 
P-value 
Using cannabis will negatively affect my health 0.03 (1.04) 0.370 
Using cannabis will give me a fun “high” 0.01 (1.01) 0.466 
I am curious about what it feels like to try 
cannabis 
-0.23 (0.90) <0.05 
Using cannabis will negatively affect my future 
(for example, sports, jobs, school) 
0.21 (1.28) <0.05 
Most people who are important to me think using 
cannabis is okay 
-0.05 (0.81) 0.228 
I have friends who use cannabis -0.09 (1.11) 0.174 
I have family members who use cannabis -0.23 (0.87) <0.05 
I will consider using cannabis to impress my 
friend(s) 




First, the use of the Delphi method showed to be an appropriate study design for reaching 
formal consensus and developing a cannabis questionnaire. The use of the cannabis knowledge 
assessment tool (C-KAT) showed that knowledge about cannabis improved after students 
participated in the REACH program via a pre-test and post-test study design. The improvement in 
student knowledge occurred within each demographic of gender, grade and school with a sample 
size greater than 25. However, the study did not find that the Behavioural Intention (BI) scale was 
useful in determining the intentions of students towards cannabis use following the REACH 
program. This chapter presents a discussion of the study results during questionnaire 
development, questionnaire testing and overall strengths and limitations.  
7.1. Questionnaire Development  
7.1.1. Development of the Cannabis Knowledge Assessment Tool 
To our knowledge, this study was the first to develop a tool to assess cannabis knowledge. 
Therefore, a method that allowed us to gain expert opinion and reach consensus during the 
development of the questionnaire was deemed valuable to increase the content validity. The 
Delphi method was used in the process, as it allowed for a large sample size of experts while 
maintaining their confidentiality from one another to avoid biases in expert responses. Hence, 
they could all answer openly and honestly without having to worry about ‘group-think’. In Round 
1, we were able to recruit 24/34 invited experts representing all five category of experts that were 
intended for adequate information retrieval. The ten experts who chose not to complete Round 1 
did not disclose the reason for their lack of participation, however it is believed that three of them 
may have been on holiday due to automated replies that were received from their email accounts 
and as the data gathering for the Delphi method began in the summer.  
Prior to round 2, the format of the C-KAT was piloted with two grade 7 students and one 
high school student. This pilot work gave researchers insight on the difficulties of different 
I will consider using cannabis to gain a sense of 
independence from my parents 
-0.07 (0.73) 0.144 
My decision to use cannabis is up to me 0.02 (1.05) 0.434 
I have a trusted adult I can talk to about cannabis -0.05 (1.25) 0.314 
I will consider using cannabis before the legal age 
in my province 
0.08 (0.88) 0.140 
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question formats for this age range of students and helped identify content difficulty or ambiguity. 
For instance, single true or false (TF) questions were deemed as too easy and students preferred 
when the question format remained the same throughout the questionnaire. Conversely, multiple-
multiple choice (MMC) questions were recognized as too difficult by the students and were 
identified by questionnaire development experts to be more appropriate for university level 
students. Compared to multiple choice (MC) questions, multiple true-false (MTF) questions allow 
for more items to be tested, with a smaller number of questions. Therefore, the questionnaire does 
not feel daunting for participants and attempts to avoid participant fatigue and skipped questions. 
Also, MTF questions more accurately identify students with misunderstandings of concepts or 
incomplete understanding, as compared to MC questions which only capture a student’s preferred 
answer and do not explore students’ thinking of the other answer options. Therefore, MC 
questions may overestimate a student’s understanding. Downsides of MTF questions that were 
discussed include the 50% chance of students guessing the correct answer or correctly indicating 
an answer as false but not knowing what the true version would be; However, when compared to 
MC questions, MTF decrease cluing and ceiling effects. Furthermore, an answer key was created 
by researchers to address the true answer for each item so students can check their understanding 
following the post-test (Appendix D). Ultimately, the MTF format allowed researchers in this 
study to test knowledge of 64 separate items within only 16 questions.  
Round 2 of the Delphi method had a loss of 3 participants. Of the three experts who did 
not participate in Round 2, one was a patient who gave no reason for their discontinuation in the 
study, one was a policymaker who was ‘out-of-office’ on their email reply, and one student 
indicated that they found the instructions and questions in Round 2 complicated and were unable 
to complete the questionnaire. Although the student expert did not continue participating in the 
Delphi method, their contribution was valuable in assessing how participants, especially other 
students, may misunderstand the instructions given for the Delphi method or could find the 
content too difficult. Based on this feedback, the instructions in subsequent emails were made 
clearer and more detailed.  
Round 2 was the only time that questions had a percent agreement lower than 70% (Q4, 
Q6, Q7, and Q9). Based on the feedback from the participants, the disagreement with these 
questions was regarding wording and difficulty of content, but not about the content being 
covered. The reason for this high percent of disagreement is likely due to Round 2 being the first 
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round of close-ended questions made by the researchers based on the results of Round 1. 
Therefore, the wording and difficulty of the questions had not yet been vetted and was far from 
the expectations of the participants, while the content was based on the results from Round 1.  
Next, in Round 3, Q1) which statements are TRUE regarding cannabis, received a much 
lower approval score when compared to all other questions in the round. This is a result of the 
changes made to the question from Round 2 to Round 3. In Round 2, the answers in Q1 included: 
A) Cannabis is natural and therefore completely safe to use, B) Cannabis can be beneficial in 
certain medical treatments but is not curative, C) Scientists and doctors know all of the adverse 
consequences of cannabis use and, D) Scientists and doctors know all of the benefits that 
cannabis may have. These answers address the theme of misunderstandings or gaps in scientific 
knowledge regarding cannabis. However, in Round 3 the answers were adjusted to: A) Cannabis 
is sometimes called marijuana, B) THC (tetrahydrocannabinol) and CBD (cannabidiol) are the 
only active ingredients in cannabis, C) The major active ingredients in cannabis are terpenes, and 
D) There are more than 400 ingredients found in cannabis. These answers involve a variety of 
themes from terminology, the active compounds in cannabis, and the composition of cannabis. In 
addition to participants suggesting that too many different topics were being approached at once 
in a question, they also noted that the question was testing trivial knowledge of cannabis instead 
of knowledge that students should know to make informed decisions about their health and 
wellness. This was valuable feedback to inform changes to the question necessary to improve the 
question.  
The last round of the Delphi method had 18 participants: three less than the previous 
round. The three participants, including one academic, one student and one policy maker, did not 
cite a reason for discontinuing their participation. While the percent agreement for most questions 
increased, Q9 (in someone using cannabis, which of the following ways may be harmful to their 
lungs) and Q16 (if you want reliable information about cannabis, where should you seek out 
information) received less than 80% agreement. The written feedback for both questions 
suggested wording changes, so this was addressed in the final version. However, it is important to 
distinguish consensus and unanimous agreement when performing the Delphi method. As most 
previous Delphi method literature indicates, 70% is an acceptable percent agreement rate. 
Therefore, changes were made to some wording in Q9 and Q16, however the content was not 
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changed as the percent agreement was already above 70% and no participants picked strongly 
disagree for either of these questions while only one picked disagree for each.   
At this point in time, it was felt that there was enough consensus to make the questionnaire 
complete without need for further feedback. This decision was based on the literature guiding the 
appropriate use of the Delphi method, and our comfort with consensus based on responses and 
open-ended feedback from participants.  
7.1.2. Development of the Behavioural Intention Scale 
In addition to measuring knowledge change, we wanted to see if taking the REACH 
program may be able to predict future behaviour with respect to cannabis use. Hence, we 
developed a Behavioural Intention (BI) scale. As a starting point to inform the BI scale, we used 
feedback written by experts in the first round of the Delphi method. Particularly, Q6 asked experts 
to indicate what information they believed was essential for youth to know about cannabis. Using 
this information, researchers drafted a BI scale which was ultimately reviewed by 6 people with 
various levels of expertise.  
The developed BI scale covered items that may factor into motivation for future 
behaviours, such as peer perception, peer pressure, perceived personal control, family influences 
and safe spaces to seek guidance; However, in the case of surveys based on behaviour, it is 
difficult to determine if the outcome of the survey is a measure of true future behaviour. Further 
studies can focus on observing actual behaviour of students, reported behaviour in schools while 
also surveying their knowledge and behavioural intentions in regard to cannabis.   
7.2. Questionnaire Testing 
The C-KAT post-test results showed that student scores had increased from the pre-test 
mean in each studied demographic with adequate sample size (grade 7, grade 9, female, male, 
Bishop James Mahoney Catholic School, Brunskill Public School and St. Lorenzo Ruiz Catholic 
School). Specifically, the scores of the grade 9 students were higher in the pre-test and the post-
test as compared to the grade 7 students. Since the REACH program has different modules for 
grade 7 and grade 9 students based on the Saskatchewan Ministry of Education’s health education 
curricular for each grade, the content variation of the program may explain this. Also, students in 
grade 9 may be exposed to more information about cannabis through media, peers and their 
families as they were older when legalization occurred, and they have additional years of ‘real 
world experience’.  No floor or ceiling effects were reported for the C-KAT as no student scored 
55 
all questions incorrect or all questions correct. Encouragingly, it appeared as if the REACH 
program was able to increase some knowledge about cannabis in all groups of participants.  
Overall, the BI scale showed no significant changes in behaviour following the REACH 
program for any demographic other than females. The female scores decreased by 0.76 points, 
which means the post-test for females had a less favourable behaviour score than the pre-test 
(P<0.05). The lack in statistically significant change and the decrease in female scores may be 
attributed to several factors. First, the female cohort had the largest sample size in the study with 
84 participants (63.6% of all participants) and cohorts such as Tommy Douglas Collegiate and 
those who identified as “other” had to be removed from statistical analysis due to small sample 
sized.  Therefore, it is possible that small sample size was a limitation for the other demographics 
and the BI scale should be explored in larger samples.   
The tool may also need to be scored differently or have certain items removed as some 
questions may be considered more important than others depending on the motivation for 
behaviour that is determined to be the most significant. For example, questions regarding 
normative beliefs, such as Most people who are important to me think using cannabis is okay may 
be deemed as less important than questions that assess attitude toward the behaviour, such as 
Using cannabis will negatively affect my health. 
Furthermore, it is possible that education programs such as REACH should not be 
expected to change behaviour and are more focused on knowledge improvement. The behavioural 
impact of such programs may be limited, especially when the program is administered over a 
short period of time with no supplemental material to prolong learning, such as take-home 
assignments. Students in grade 7 and 9 may already have set behavioural intentions regarding 
substance use by this age and therefore the REACH program did not change their perceptions of 
this behaviour.   
Another possible explanation for the lack of meaningful improvement in the BI scale 
scores is the time between completion of the REACH program and administration of the post-
tests. For instance, for Brunskill Public School and Bishop James Mahoney Catholic School, the 
post tests were performed one week following the completion of REACH while at Tommy 
Douglas Collegiate, the post-test was administered immediately following their last lesson and for 
St. Lorenzo Ruiz Catholic School, the post-test occurred the day following their last REACH 
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lesson. The timeline of post-tests must be considered in future studies to determine if this is an 
important variable.  
A significant change was not observed between the pre-test and post-test scores on the BI 
scale when broken down to each demographic; however, it was found that the true mean BI score 
for the questions I am curious about what it feels like to try cannabis and I have family members 
who use cannabis after the REACH program was significantly lower than the true mean BI score 
for the questions before the REACH program (p <0.05). This may indicate that students may be 
more curious about what it feels like to try cannabis following the REACH program. Also, it is 
possible that students have a better understanding of what cannabis is and realize that they do 
have family members who use it. Students may have also spoken with their parents or family 
members more openly about cannabis use while learning about cannabis at school and learned 
that their family members do use cannabis for medical or recreational purposes, thus more 
students answered that they have family members who use cannabis. In theory, the scores for I 
have family members who use cannabis should have remained the same between the pre- and 
post-test since it is unexpected that a significant number of students would have changed their 
answer to this question in such a short time frame. Conversely, scores for the question using 
cannabis will negatively affect my future (for example, sports, jobs, school) after the REACH 
program became more favorable (p<0.05). Perhaps after the education the students became aware 
of the negative consequences of cannabis use. Nevertheless, it is still important to not draw too 
many inferences from this one response because as a whole, the BI scale did not appear to capture 
any future changes in participants behavioural intentions.  
7.3. Strengths and Limitations 
In literature pertaining to the use of the Delphi method, the selection of experts is 
highlighted as a key step in ensuring success for the study. Some criteria include having a 
minimum of 10 participants and upward of 50 to 100, with 5 to 10 participants per discipline of 
expertise. In this study, seven healthcare professionals, six policymakers, eight patients, six 
academics, and seven students were invited to participate, and in Round 1 six health care 
professionals, five policymakers, four patients, three academics in the field, and five students 
participated. This composition of respondents closely follows the criteria set by previous Delphi 
methods. Furthermore, while the retention rate of the Delphi method can be low, this study 
retained 78% of participants.  These participants all had adequate and equal opportunity for 
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providing feedback as every question in the Delphi method had a comment box for additional 
suggestions outside of only choosing on the Likert-scale. Due to the maintenance of 
confidentiality by researchers, participants were able to freely express their thoughts and no 
dominating opinions biased the input of others. Therefore, the C-KAT was developed through the 
appropriate use of a validated method in consensus development.  
Limitations to the study must also be considered. First, during the expert selection process 
for the Delphi method, middle and high school educators were not specifically included in the 
participant list. Although some experts had a previous background in youth education, there were 
no current teachers or teaching assistants. Educators from elementary schools, middle schools and 
high schools would have been beneficial to determine the understandability of the questionnaire 
for the students and for use in the general public. As teachers have first-hand experience with 
reading levels and student comprehension, their involvement would increase the accessibility of 
the questionnaire. The piloting of the questionnaire was also only completed in three students, 
which may not have allowed for a variety of reading levels to be assessed and adjusted for. 
Piloting the post-Round 4 questionnaire in a class of students would also have been beneficial for 
greater feedback on readability prior to finalization of the questionnaire.   
Another limitation is the retention rate of participants decreased throughout the Delphi 
method, other than between Round 2 and Round 3, so a nonresponse bias must be considered. 
While participants who decided to not respond or to not continue responding to the Delphi 
method may have missed their email invitation or been on holiday, it is also possible that they had 
different views compared to the overall study or changes that were being made to the 
questionnaire. For instance, some chosen experts may not agree with in-school cannabis 
curriculums and chosen not to participate. Next, some experts may have disagreed with the 
direction of the questionnaire and discontinued their participation in subsequent rounds. In 
addition to nonresponse bias, the open-ended style questions of Round 1 in the Delphi method and 
the iterative multistep approach may have been discouraging, especially for participants who had 
already busy schedules. Researchers attempted to maximize participant retention through 
anonymity of answers and other steps that have been proven to effect retention, such as 
personalized emails and reminder emails.  
The study identified areas of improvement in questionnaire development and testing. First, 
emergent coding was used for the answers to the open-ended questions in Round 1 of the Delphi 
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method. While emergent coding is appropriate for broad and exploratory questions, such as those 
in Round 1, it is not as rigorous as established coding. Therefore, emergent coding does not allow 
researchers to identify frequency of themes or the relationship between them as appropriately as 
established coding may. Also following Round 1, a principal component analysis (PCA) was 
performed on the themes noted from Q 1) What essential information should the general public 
know about cannabis. While Q1 offers a summarized insight into what experts expect from a 
cannabis knowledge assessment tool, a PCA on the other questions of Round 1 could also help 
researchers encompass other themes that may have been missed during their item reduction.  
The rigor of the Delphi method for the development of the C-KAT may also be necessary 
for the development of the BI scale to improve the quality of the scale. Furthermore, the timing of 
the pre-test and post-test should be evaluated to better evaluate changes in knowledge and 
behaviour in cohorts of students. For instance, one week may not be enough time following the 
REACH program for behavioural changes to occur and effect the answers of the students on the 
BI scale. Also, it is important to determine if knowledge obtained from cannabis education 
programs, such as REACH, remains in the months or years following the curriculum.  
While public and Catholic schools from different geographical locations in Saskatoon, 
Saskatchewan were studied, sampling bias may continue to exist. The seven schools were chosen 
as they were accommodating of the REACH program and had teachers that were willing to have 
their classes participate in both REACH and the pre- and post-testing. Researchers must consider 
more vulnerable youth populations who may attend school or classes less often or may not be 
enrolled in school. While such populations are more at risk for harmful cannabis use and should 
be addresses, they would unfortunately not be encompassed in the study sample. Also, the 
presence of volunteer bias must be considered in the student population who completed the 
questionnaire. This volunteer bias is a result of the consent required from parents for students to 
participate in the study. Parents who are willing to educate their children on cannabis and have 
their children be educated in the school system regarding substance use are more likely to consent 
to the study, while those who are opposed to this form of education are likely to not allow their 
children to participate. This acceptance by the parents of the participating students may also have 
effects on the behavioural intention scale and knowledge assessment tool. For instance, these 
students may have prior knowledge regarding cannabis and health from their families, which may 
skew the results of the knowledge assessment tool to be higher than it would be in the general 
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public. This may account for the high overall pre-test scores in the C-KAT and BI scale. 
Therefore, the sample population in this study may not be generalizable to other youth and 
adolescents, particularly those who may be more vulnerable.  
As a result of the COVID-19 pandemic and school closures, the post-tests were taken by 
students closely following their completion of the REACH program but due to school closure 
during the COVID-19 pandemic, a response rate of 32% was recorded. Additionally, the timing of 
the pre-tests and post-tests varied between classrooms. For Brunskill Public School and Tommy 
Douglas Collegiate, the pre-test was administered immediately prior to the first REACH lesson 
while the pre-test was administered a week and half prior to the first lesson at St. Lorenzo Ruiz 
Catholic School and one day prior to the first lesson at Bishop James Mahoney Catholic School. 
This approach does not allow researchers to disregard timing of the tests as a variable for the 
results and must be observed in future studies.  
At each school, teachers were present during administration of the pre- and post-test. 
Some teachers chose to participate by handing out questionnaires or proctoring the assessments 
while others stepped back while researchers lead the process. Having teachers present during 
administration of the questionnaire may make students perform differently on the C-KAT and BI 
scale when their teachers are in the room watching them answer questions as this removes the 
anonymity from their answers. Also, in some cases when the researcher was busy addressing one 
student’s question, the teacher would approach other students who wanted to ask questions. In 
these cases, the teacher could see the students answers and could give false information or guide 
them to the correct answer which would interfere with the study results. In future iterations of the 
study, it would be useful to ensure that all teaching staff are given instructions to observe the 
study process without giving their input or discipline to students during the test taking as this may 
confound the results, or ideally to be removed from the room altogether. Also, as the BI scale is a 
self-reported measure of behaviour, researchers must consider self-report bias. The responses on 
the BI scale may be exaggerated, due to aspects of peer pressure or insecurity, or can be 
downplayed due to respondent’s embarrassment to reveal private details. For instance, students 
may feel reluctant to admit to certain behaviours, such as consuming cannabis before the legal 
age, or may not remember certain details, such as friends or family members using cannabis. 
Therefore, what students reported on the BI scale may not truly measure their future actions and a 
study design including direct observation of future actions would be more appropriate.  
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Ultimately, this study relied on a questionnaire design which has limitations including 
sampling bias, volunteer bias, nonresponse bias, self-response bias and more. Other areas of 
concern with questionnaires include problems with wording (ambiguous questions, complexity, 
vague words), scale formats, intrusiveness for sensitive questions and response fatigue. As a result 
of these limitations, capturing concepts accurately in survey-based research poses problems and 
researchers should aim to minimize these biases as much as possible in future iterations of the 
study.    
7.4. Conclusion 
To our knowledge, this was the first time that a tool was developed and tested to assess 
knowledge about and intentions towards cannabis use. The study aimed to determine if the 
Cannabis Knowledge Assessment Tool and the Behavioural Intention Scale captured changes in 
knowledge and behaviour intention in populations undergoing cannabis education. In this 
convenience sample of grade 7 and 9 students who participated in a cannabis educational 
program, knowledge about cannabis improved, but no significant change was evident in 
behaviour intention scores with respect to cannabis use. Future studies are required to test the C-





















             Participant Consent Form 
 




Thank you for taking the time to read this letter – we know you are busy! Your child will 
be learning about cannabis in school in the next couple of weeks as part of their health 
class. This will be taught by nurses and nursing students through the Real Education 
About Cannabis and Health (REACH) program, which is a program that we developed 
last year with the help of students from a few different Saskatoon schools. 
 
We would like to know if the REACH program improves knowledge about cannabis, and if 
the knowledge learned through the program may predict future behaviour. Hence, we are 
inviting students to participate in a study by filling out two paper questionnaires. The first 
questionnaire will be completed before the students receive their cannabis education, and the 
second questionnaire will be completed after the completion of the cannabis education. In 
short, we want to determine if the REACH program is useful to help kids increase their 
knowledge about cannabis, so that they are able to make healthy decisions. 
 
There are no known or anticipated risks to students by participating in this research. 
Although the data from this research project may be published or presented at conferences, 
the results will only be presented as a summary of all responses, so it will not be possible to 
identify individual answers. Further, your child will be instructed not to use their names on 
their answer sheet, so that the answers can remain completely anonymous. The 
questionnaires will be kept in a locked filing cabinet in the locked office of Dr. Kerry 
Mansell for a period of 5 years post-publication, after which time they will be destroyed by 
confidential shredding. 
 
Whether your child participates or not will have no effect on their class standing or how they 
will be treated. Your child’s participation is voluntary, and they do not have to answer any 
questions they are not comfortable with. They may withdraw from the study for any reason 
without explanation or penalty of any sort. In addition to your consent for your child to 
participate, they must also give their assent to participate which is done by filling out the 
questionnaire (they do not have to sign a form). 
 
Should you or your child wish to withdraw your child from participating at any time, please 
contact one of the following researchers: Ava Bayat; Graduate Student, College of Pharmacy 
and Nutrition, University of Saskatchewan, email: avb513@mail.usask.ca or Dr. Kerry 
Mansell, Professor, College of Pharmacy and Nutrition, University of Saskatchewan, email: 
kerry.mansell@usask.ca; phone: (306) 966-5235. If you or your child wish to withdraw their 
data after the study ends (before March 31st, 2020), or if you would like to see a summary of 
the findings, please contact Dr. Kerry Mansell (email: kerry.mansell@usask.ca; phone: (306) 
966- 5235). 
 
This research project has been approved on ethical grounds by the University of 
Saskatchewan Behavioural Research Ethics Board. Any questions regarding your rights as a 
participant may be addressed to that committee through the Research Ethics Office 
(ethics.office@usask.ca; (306) 966-2975). Out of town participants may call toll free (888) 
966-2975. 
 
Thank you for considering! 
 
 
My child(ren),  has (have) my permission to 
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participate in this study assessing cannabis knowledge and predicted behaviour after learing 
about cannabis in the REACH program. 
 
 
































APPENDIX B: STUDENT ASSENT FORM  
     
 
 
                     Participant Information 
 
 
Date:   Your Unique Code Name:   
 
 
Grade:   Gender:  Male   / Female / Other 
 
 
Cannabis Knowledge and Behavioural Intention 
 
 
Welcome to the Real Education About Cannabis and Health (REACH) program. We hope 
that you find it interesting and informative! 
 
We hope that you will fill out the questionnaire attached to this letter. It should not take you 
any more than 15 minutes to complete. The questionnaire will ask you questions about your 
knowledge and feelings towards cannabis. Please answer the questions honestly and the best 
that you can. 
 
If you are reading this sheet, your parents have signed a consent form saying that you can 
participate. The decision to complete this questionnaire is up to you. If you choose not to fill 
it out, it will not affect your grades or your relationship with the instructors or teachers. You 
do not have to answer any questions you are not comfortable with, and you may withdraw 
from the study for any reason without explanation or penalty of any sort. 
 
If you choose to participate, please enter the date, what grade you are in, and your gender 
identification in the spaces above. Also, please choose a code name that will be unique to 
you and that nobody else will know. We will provide you tips to ensure that it is unique to 
you. It is important to remember this code name, and not share it with anyone. None of the 
researchers will know your code name, and so your answers will be completely anonymous 
and will not be shared with anyone. All of the responses will be grouped together, and so 
your individual answers will not be reported – you will remain anonymous. The 
questionnaires will be kept in a locked filing cabinet in the locked office of Dr. Kerry 
Mansell for a period of 5 years post- publication, after which time they will be destroyed by 
confidential shredding. 
 
If you have any questions, please feel free to ask one of the REACH leaders, the study 
coordinator, or your teacher. By completing and submitting this questionnaire, YOUR FREE 
AND INFORMED ASSENT IS IMPLIED, and indicates that you understand the above 
conditions of participation in this study. If you would like to withdraw your data after the study 
ends (before March 31st, 2020), or if you would like to see a summary of the findings, please 
contact Dr. Kerry Mansell (email: kerry.mansell@usask.ca; phone: (306) 966-5235). 
 
This research project has been approved on ethical grounds by the University of 
Saskatchewan Behavioural Research Ethics Board. Any questions regarding your rights as a 
participant may be addressed to that committee through the Research Ethics Office 








APPENDIX C: THE QUESTIONNAIRE, C-KAT PORTION 
Questionnaire About Cannabis 
 
√ CHECK ONLY THE CORRECT ANSWERS (YOU MAY CHOOSE MORE THAN 
ONE ANSWER). 
 
1. Which statements are TRUE regarding the compounds (ingredients) in cannabis? (check all 
of the correct answers) 
 
 THC (tetrahydrocannabinol) is what causes people to feel “high” 
 CBD (cannabidiol) is what causes people to feel “high” 
 Terpenes are what cause people to feel “high” 
 Cannabis used for medical conditions may contain both THC and CBD 
 
2. Which statements are TRUE regarding cannabis terms? (check all of the correct answers) 
 
 Cannabis is sometimes called “marijuana”, “weed”, or “pot” 
 The terms “sativa” and “indica” refer to different cannabis plants 
 Cannabis with a high amount of THC is called “hemp” 
 The term “cannabinoids” refers to the compounds in cannabis, such as THC and CBD 
 
3. Which statements about cannabis are TRUE? (check all of the correct answers) 
 
 Cannabis is natural, so that means that it is safe to use 
 Scientists and health care professionals know all of the potential harmful effects of 
cannabis 
 Scientists and health care professionals know all of the potential benefits of cannabis 
 More research is needed to know all the effects of cannabis 
 
4. Which statements are TRUE regarding the effects of cannabis? (check all of the 
correct answers) 
 
 Inhaling cannabis provides the fastest effects 
 The effects one person feels may be different than the effects another person feels 
 The time it takes to feel the effects of cannabis can be different for everyone 
 People typically feel the effects of edible cannabis within 10 minutes 
 
5. Based on what is known about potential harms, who should avoid using recreational 
cannabis? (check all of the correct answers) 
 
 Someone who is pregnant or breastfeeding 
 Someone that is older than 65 years old 
 Someone who has a substance use disorder 
 Someone with a personal or family history of psychosis (for example, schizophrenia) 
 
6. Unless you are being treated for a medical condition by a health care professional, why is it 
important to avoid using cannabis before the age of 25? (check all of the correct answers) 
 
 Using cannabis is not legal until you are 25 
 Using cannabis before 25 may increase the risk of depression later in life 
 You can become addicted to cannabis if you use it before 25, but not after 
 The human brain does not fully develop until around the age of 25 
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7. People considering cannabis for a medical condition should: (check all of the correct answers) 
 
 Speak to a health care professional (for example, doctors, pharmacists or nurses) 
 Try cannabis from a licensed retailer 
 Try some cannabis from their friends first to see if it may work 
 Try edibles first 
 
8. What are some of the potential short-term negative effects of using cannabis? (check all of 
the correct answers) 
 
 Difficulty focusing and confusion 
 Lung cancer 
 Increased heart rate 
 Slower reflexes 
 
9. Which of the following ways of using cannabis may be harmful to someone's lungs? (check 
all of the correct answers) 
 
 Smoking cannabis 
 Eating cannabis 
 Vaping cannabis 
 Rubbing cannabis on their skin 
 
10. If someone uses a large amount of cannabis for a long time and then suddenly stops, what 
are some of the withdrawal symptoms they might experience? (check all of the correct 
answers) 
 
 Mood changes, such as increased anxiety 
 Better ability to focus 
 Difficulty sleeping 
 There are no known withdrawal symptoms 
 
 
11. Which statements are TRUE about recreational cannabis use in Canada? (check all of 
the correct answers) 
 
 The legal age for using it in all provinces is 18 years old 
 The laws for possession are the same in all Canadian provinces 
 You can buy it from licensed online sellers 
 You can grow as much as you want in your home if it is for personal use 
 
12. Which statements are TRUE regarding the regulation of cannabis? (check all of the 
correct answers) 
 
 You need medical authorization to purchase cannabis from a licensed retailer 
 You can legally purchase recreational cannabis from anyone 
 Licensed producers have similar rules for making both medical and 
recreational cannabis 
 Stores that sell cannabis can only sell products that are guaranteed to have the same 
ingredients in them every time 
66 
13. Which statements are TRUE regarding Canadian cannabis laws? (check all of the 
correct answers) 
 
 The maximum amount of cannabis you can carry in public is 30 grams of dried cannabis 
 Drug-impaired driving is not allowed at any time 
 You can use cannabis in a parked vehicle 
 The laws for consuming cannabis in a public space are the same all across Canada 
 
14. If cannabis is used, which decisions may be helpful for reducing harm? (check all of 
the correct answers) 
 
 Avoid driving for at least six hours after using cannabis 
 Buy cannabis from a licensed retailer 
 Do not use cannabis until you are at least 25 years old 
 Use cannabis with a lower THC content 
 
15. Which statements are TRUE regarding cannabis and travel? (check all of the 
correct answers) 
 
 Bringing cannabis into Canada is illegal 
 Leaving Canada with cannabis is illegal 
 You may not be able to enter the USA if you have used cannabis 
 You can take cannabis to other countries if it is also legal there 
 
16. Where should you seek out reliable information about cannabis? (check all of the correct 
answers) 
 
 Health care professionals (for example, doctors, pharmacists or nurses) 
 Government of Canada website 
 Retail stores that sell cannabis 








APPENDIX D: THE QUESTIONNAIRE, C-KAT PORTION WITH ANSWERS  
√ CHECK ONLY THE CORRECT ANSWERS (YOU MAY CHOOSE MORE THAN ONE). 
 
1. Which statements are TRUE regarding the compounds (ingredients) in cannabis? (check all 
of the correct answers) 
 
 THC (tetrahydrocannabinol) is what causes people to feel “high” 
 CBD (cannabidiol) is what causes people to feel “high” 
 Terpenes are what cause people to feel “high” 
 Cannabis used for medical conditions may contain both THC and CBD 
 
Cannabis contains more than 400 compounds. Some of these compounds are terpenes and 
cannabinoids. Terpenes are responsible for the smell of cannabis. There are more 
cannabinoids than just CBD and THC, but these are the most researched. THC is what 
causes people to feel “high”, but CBD does not. Medical cannabis may have both THC and 
CBD. 
 
2. Which statements are TRUE regarding cannabis terms? (check all of the correct answers) 
 
 Cannabis is sometimes called “marijuana”, “weed”, or “pot” 
 The terms “sativa” and “indica” refer to different cannabis plants 
 Cannabis with a high amount of THC is called “hemp” 
 The term “cannabinoids” refers to the compounds in cannabis, such as THC and 
CBD 
 
“Hemp” comes from the sativa cannabis plant and has low levels of THC compared to 
other forms of cannabis. 
 
3. Which statements about cannabis are TRUE? (check all of the correct answers) 
 
 Cannabis is natural, so that means that it is safe to use 
 Scientists and health care professionals know all of the potential harmful effects of 
cannabis 
 Scientists and health care professionals know all of the potential benefits of cannabis 
 More research is needed to know all the effects of cannabis 
 
Even though cannabis is natural, that does not mean it is safe for use. More research is needed 
to know about all of the positive and negative effects of cannabis. Scientists and health care 
professionals are still learning! 
68 
4. Which statements are TRUE regarding the effects of cannabis? (check all of the 
correct answers) 
 
 Inhaling cannabis provides the fastest effects 
 The effects one person feels may be different than the effects another person feels 
 The time it takes to feel the effects of cannabis can be different for everyone 
 People typically feel the effects of edible cannabis within 10 minutes 
 
While the effects one person feels may be different than the effects another person feels, 
smoking (inhaling) cannabis provides the fastest effects. Edibles are slower acting and start 
having an effect between 30 minutes to 2 hours after. 
 
5. Based on what is known about potential harms, who should avoid using recreational 
cannabis? (check all of the correct answers) 
 
 Someone who is pregnant or breastfeeding 
 Someone that is older than 65 years old 
 Someone who has a substance use disorder 
 Someone with a personal or family history of psychosis (for example, schizophrenia) 
 
The Canadian government suggests that people who are pregnant and/or breastfeeding avoid 
cannabis completely. The Canadian government also suggests that people who are at risk 
for mental health problems, specifically psychosis and problematic substance use, avoid 
cannabis completely. Healthy individuals over the age of 65 are able to use cannabis safely 
but can speak to a health care professional about it! 
 
 
6. Unless you are being treated for a medical condition by a health care professional, why is 
it important to avoid using cannabis before the age of 25? (check all of the correct answers) 
 
 Using cannabis is not legal until you are 25 
 Using cannabis before 25 may increase the risk of depression later in life 
 You can become addicted to cannabis if you use it before 25, but not after 
 The human brain does not fully develop until around the age of 25 
 
Cannabis is legal at 18 in Alberta and Quebec but 19 in all other provinces. There is 
research that has shown a higher risk of depression when cannabis is used before the age of 
25. Since the human brain does not fully develop until around the age of 25, those who use 
cannabis before 25 may experience more long-term mental health effects. You can become 
addicted to cannabis at any age. 
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7. People considering cannabis for a medical condition should: (check all of the correct answers) 
 
 Speak to a health care professional (for example, doctors, pharmacists or nurses) 
 Try cannabis from a licensed retailer 
 Try some from their friends first to see if it may work 
 Try edibles first 
 
People who want to try cannabis to help them with a medical condition should always 
speak to a health care professional first. They should not try cannabis from other people, 
edibles or buying it from a retailer without getting medical advice from a professional. 
 
8. What are some of the potential short-term negative effects of using cannabis? (check all of 
the correct answers) 
 
 Difficulty focusing and confusion 
 Lung cancer 
 Increased heart rate 
 Slower reflexes 
 
Some short-term negative effects of cannabis include difficulty focusing, confusion, 
increased heart rate and slower reflexes. Lung cancer may result from long-term cannabis 
inhalation. 
 
9. Which of the following ways of using cannabis may be harmful to someone's lungs? (check 
all of the correct answers) 
 
 Smoking cannabis 
 Eating cannabis 
 Vaping cannabis 
 Rubbing cannabis on their skin 
 
Lungs are affected by inhaling cannabis, which includes smoking it and vaping it. Rubbing 
cannabis on their skin may cause a rash and itching. 
 
10. If someone uses a large amount of cannabis for a long time and then suddenly stops, what 
are some of the withdrawal symptoms they might experience? (check all of the correct 
answers) 
 
 Mood changes, such as increased anxiety 
 Better ability to focus 
 Difficulty sleeping 
 There are no known withdrawal symptoms 
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Withdrawal symptoms of cannabis include mood changes, difficulty sleeping, loss of 
focus, cravings for cannabis, changes in appetite, headaches and more. 
 
 
11. Which statements are TRUE about recreational cannabis use in Canada? (check all of 
the correct answers) 
 
 The legal age for using it in all provinces is 18 years old 
 The laws for possession are the same in all Canadian provinces 
 You can buy it from licensed online sellers 
 You can grow as much as you want in your home if it is for personal use 
 
The legal age for cannabis use in Alberta and Quebec is 18 but in all other provinces you 
must be 19 years old to legally use cannabis. The laws for possession of cannabis vary 
between provinces, including the amount you can have on you. In Manitoba and Quebec, 
you are not allowed to grow any cannabis in your home. In other provinces, adults can 
legally grow up to four cannabis plants but must follow the laws for growing cannabis in 
the home. 
 
12. Which statements are TRUE regarding the regulation of cannabis? (check all of the 
correct answers) 
 
 You need medical authorization to purchase cannabis from a licensed retailer 
 You can legally purchase recreational cannabis from anyone 
 Licensed producers have similar rules for making both medical and 
recreational cannabis 
 Stores that sell cannabis can only sell products that are guaranteed to have the same 
ingredients in them every time 
 
Anyone over the legal age limit is able to purchase cannabis from a licensed retailer in 
Canada. Recreational cannabis can only be purchased legally from a licensed retailer. The 
amount of ingredients (including THC and CBD) in each batch of product vary, even if it is 
purchased from the same licensed retailer. 
 
13. Which statements are TRUE regarding Canadian cannabis laws? (check all of the 
correct answers) 
 
 The maximum amount of cannabis you can carry in public is 30 grams of 
dried cannabis 
 Drug-impaired driving is not allowed at any time 
 You can use cannabis in a parked vehicle 
 The laws for consuming cannabis in a public space are the same all across Canada 
 
While some provinces allow drivers to use a small amount of cannabis if they are above the 
legal age, no province allows driving while impaired. Using cannabis in a parked 
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vehicle is illegal. If cannabis is being transported in a vehicle, it should not be 
within reach of the driver or passengers. 
 
14. If cannabis is used, which decisions may be helpful for reducing harm? (check all of 
the correct answers) 
 
 Avoid driving for at least six hours after using cannabis 
 Buy cannabis from a licensed retailer 
 Do not use cannabis until you are at least 25 years old 
 Use cannabis with a lower THC content 
 
A minimum of six hours after cannabis use is suggested before driving a vehicle to avoid 
drug-impairment and potential harm to yourself or others. 
To make sure the cannabis you are using is regulated and does not contain other harmful 
drugs, only purchase cannabis from a licensed retailer. 
The human brain does not fully develop until around the age of 25. Using cannabis before 
this age may affect mental development and lead to higher risks of anxiety or depression 
later on. 
THC is what causes people to feel “high.” Cannabis with lower amounts of THC 
is recommended. 
 
15. Which statements are TRUE regarding cannabis and travel? (check all of the 
correct answers) 
 
 Bringing cannabis into Canada is illegal 
 Leaving Canada with cannabis is illegal 
 You may not be able to enter the USA if you have used cannabis 
 You can take cannabis to other countries if it is also legal there 
 
It is illegal to bring cannabis into Canada and to travel outside of Canada with cannabis. 
Even if cannabis is legal in other countries, it is illegal to travel to those countries with 
cannabis. If you have used cannabis before you may not be allowed to enter the USA. 
 
16. Where should you seek out reliable information about cannabis? (check all of the 
correct answers) 
 
 Health care professionals (for example, doctors, pharmacists or nurses) 
 Government of Canada website 
 Retail stores that sell cannabis 
 Your peers who are using cannabis 
 
You can get reliable information about cannabis from a health care professional and from 
the Government of Canada website. Cannabis retail stores and your peers may have 
misinformation about cannabis. 
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APPENDIX E: DELPHI METHOD FIRST EMAIL CORRESPONDENCE  
Dear Jane Doe,  
 
Greetings. My name is Ava Bayat, and I am a graduate student in the College of Pharmacy and 
Nutrition at the University of Saskatchewan. The purpose of my master’s thesis is to make a tool 
to assess knowledge about cannabis. You have been identified by our research team as having 
expertise or an interest in this area. As such, I am hoping that you may be able to help out with 
our project. 
 
As cannabis is now legal and increasing in popularity, there is a need to understand what our 
youth knows about cannabis. A knowledge tool will help assess cannabis knowledge and be 
useful for guiding and evaluating education programs. 
 
To make this tool, we will use the Delphi Method to reach an agreement amongst all of the 
participants. Participants include health care professionals, policy makers, patients, academics, 
and students. There will be approximately 25 participants in total. 
 
Participating in this project will involve taking part in three separate questionnaires. 
• The first survey (round 1) will involve open-ended questions about what you feel should 
be included on a cannabis knowledge assessment tool 
• The second and third surveys (rounds 2 and 3) will consist of follow up questions that 
will be developed based on the information gathered from the first survey 
We would like to invite you to participate in the first questionnaire. 
 
Your answers to these questions will be kept confidential, and your identity will not be shared 
with the other participants. Your decision to take part is voluntary. If you choose to participate, 
we kindly ask that you complete the survey by July 18th, 2019. Each survey will take about 15 
minutes to complete. 
 
If you have any questions or concerns, please feel free to email me at any time. I am also happy 
to chat in person if that is easier; my contact information is provided at the end of this email. 
 
This survey is hosted by SurveyMonkey, a USA owned company so the privacy of the 
information you provide may be subject to USA laws. By participating in this survey, you 
acknowledge and agree that your answers will be stored in Canada, but they may or may not 
receive the Canadian law’s level of privacy protection. Your responses in the survey will remain 
anonymous. A copy of the research data will remain on Kerry Mansell’s protected computer for 
a minimum of five years as per University of Saskatchewan Guidelines. 
 
By completing the questionnaire, YOUR FREE AND INFORMED CONSENT IS 




A link to this questionnaire can be found at XXX. 
 
This research project has been approved on ethical grounds by the University of Saskatchewan 
Research Ethics Board. For any questions regarding your rights as a participant please contact 
the committee through the Research Ethics Office: ethics.office@usask.ca or (306) 966-2975. 
Out of town participants may call toll free: (888) 966-2975. If you have any questions about the 
project itself, you may contact myself (Ava Bayat) or Kerry Mansell (principal investigator) at 
(306) 966-5235 or kerry.mansell@usask.ca. A summary of the research results will be offered 
through email following the last round of surveys. 
 
Thank you for your time, 
 
Ava Bayat, MSc student 



















APPENDIX F: SUBSEQUENT ROUND EMAIL  




Thank you so much for participating in our project to make a tool to assess knowledge 
about cannabis use. We know that your time is valuable, and we truly appreciate your help! Your 
opinions are extremely important as they are guiding the tool development process. 
  
Please click on the link below to complete a follow-up survey, which is based on the feedback 
from Round 1.  XXXXX. 
 
  
Your answers in the survey will be kept confidential, and your identity will not be shared with 
the other participants. Your decision to take part is voluntary. If you choose to participate, we 
kindly ask that you complete the survey by September 16th, 2019. Each survey will take 
about 15 minutes to complete. 
  
If you have any questions or concerns, please feel free to email me at any time; my contact 
information is provided at the end of this email. 
  
This survey is hosted by SurveyMonkey, a USA owned company so the privacy of the 
information you provide may be subject to USA laws. By participating in this survey, you 
acknowledge and agree that your answers will be stored in Canada but they may or may not 
receive the Canadian law’s level of privacy protection. Your responses in the survey will remain 
anonymous. A copy of the research data will remain on Kerry Mansell’s protected computer for 
a minimum of five years as per University of Saskatchewan Guidelines. 
  
By completing the survey, YOUR FREE AND INFORMED CONSENT IS IMPLIED and 
indicates that you understand the conditions of participation in this study as mentioned above. 
  
This research project has been approved on ethical grounds by the University of Saskatchewan 
Research Ethics Board. For any questions regarding your rights as a participant please contact 
the committee through the Research Ethics Office: ethics.office@usask.ca or (306) 966-2975. 
Out of town participants may call toll free: (888) 966-2975. If you have any questions about the 
project itself, you may contact myself (Ava Bayat) or Kerry Mansell (principal investigator) at 
(306) 966-5235 or kerry.mansell@usask.ca. A summary of the research results will be offered 
through email following the last round of surveys. 
  
Thank you for your time. We look forward to sharing more results in the next round of the 
project.   
Ava Bayat, MSc student 




APPENDIX G: REMINDER EMAIL 
Dear Jane Doe,  
 
About two weeks ago, you received an email inviting you to take part in a survey about a tool for 
assessing cannabis knowledge. 
 
If you have not had a chance to complete the survey yet, we would still love to hear from you! 
We are asking health care professionals, policy makers, patients, academics, and students to help 
us identify what topics the knowledge tool should cover. 
 
To complete the survey, please go to the link below: XXXX.  
 
Your answers in the survey will be kept confidential, and your identity will not be shared with 
the other participants. Your decision to take part is voluntary. If you choose to participate, 
we kindly ask that you complete the survey by July 26th. Each survey will take about 15 minutes 
to complete. 
 
If you have any questions or concerns, please feel free to email me at any time. I am also happy 
to chat in person if that is easier; my contact information is provided at the bottom of this email. 
 
This survey is hosted by SurveyMonkey, a USA owned company so the privacy of the 
information you provide may be subject to USA laws. By participating in this survey, you 
acknowledge and agree that your answers will be stored in Canada but they may or may not 
receive the Canadian law’s level of privacy protection. Your responses in the survey will remain 
anonymous. A copy of the research data will remain on Kerry Mansell’s protected computer for 
a minimum of five years as per University of Saskatchewan Guidelines. 
 
By completing the survey, YOUR FREE AND INFORMED CONSENT IS IMPLIED 
and indicates that you understand the conditions of participation in this study as mentioned 
above. 
 
This research project has been approved on ethical grounds by the University of Saskatchewan 
Research Ethics Board. For any questions regarding your rights as a participant please contact 
the committee through the Research Ethics Office: ethics.office@usask.ca or (306) 966-2975. 
Out of town participants may call toll free: (888) 966-2975. If you have any questions about the 
project itself, you may contact myself (Ava Bayat) or Kerry Mansell (principal investigator) at 
(306) 966-5235 or kerry.mansell@usask.ca. A summary of the research results will be offered 
through email following the last round of surveys. 
 
Thank you for your time, 
 
Ava Bayat, MSc student 




APPENDIX H: FINAL REMINDER EMAIL 
Final Reminder-Responses due Friday, August 9th 
 
Dear Jane Doe, 
 
About a month ago, you received an email inviting you to take part in a survey about a tool for 
assessing cannabis knowledge. 
 
If you have not had a chance to complete the survey yet, we would still love to hear from you! 
We are asking health care professionals, policy makers, patients, academics, and students to help 
us identify what topics the knowledge tool should cover. 
 
A link to this questionnaire can be found at XXXXX.  
 
Your answers in the survey will be kept confidential, and your identity will not be shared with 
the other participants. Your decision to take part is voluntary. If you choose to participate, 
we kindly ask that you complete the survey by this Friday, August 9th. Each survey will take 
about 15 minutes to complete. 
 
If you have any questions or concerns, please feel free to email me at any time.  
 
This survey is hosted by SurveyMonkey, a USA owned company so the privacy of the 
information you provide may be subject to USA laws. By participating in this survey, you 
acknowledge and agree that your answers will be stored in Canada but they may or may not 
receive the Canadian law’s level of privacy protection. Your responses in the survey will remain 
anonymous. A copy of the research data will remain on Kerry Mansell’s protected computer for 
a minimum of five years as per University of Saskatchewan Guidelines. 
 
By completing the survey, YOUR FREE AND INFORMED CONSENT IS IMPLIED and 
indicates that you understand the conditions of participation in this study as mentioned above. 
 
This research project has been approved on ethical grounds by the University of Saskatchewan 
Research Ethics Board. For any questions regarding your rights as a participant please contact 
the committee through the Research Ethics Office: ethics.office@usask.ca or (306) 966-2975. 
Out of town participants may call toll free: (888) 966-2975. If you have any questions about the 
project itself, you may contact myself (Ava Bayat) or Kerry Mansell (principal investigator) at 
(306) 966-5235 or kerry.mansell@usask.ca. A summary of the research results will be offered 
through email following the last round of surveys. 
 
Thank you for your time, 
 
Ava Bayat, MSc student 
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